<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="chapter-article"><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><?covid-19-tdm?><?noissn?><front><journal-meta><journal-id journal-id-type="publisher-id">978-3-319-54567-7</journal-id><journal-id journal-id-type="doi">10.1007/978-3-319-54567-7</journal-id><journal-id journal-id-type="nlm-ta">Human Virology in Latin America</journal-id><journal-title-group><journal-title>Human Virology in Latin America</journal-title><journal-subtitle>From Biology to Control</journal-subtitle></journal-title-group><isbn publication-format="print">978-3-319-54566-0</isbn><isbn publication-format="electronic">978-3-319-54567-7</isbn></journal-meta><article-meta><article-id pub-id-type="pmcid">7121549</article-id><article-id pub-id-type="publisher-id">12</article-id><article-id pub-id-type="doi">10.1007/978-3-319-54567-7_12</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Human Respiratory Syncytial Virus: Biology, Epidemiology, and Control</article-title></title-group><contrib-group content-type="book editors"><contrib contrib-type="editor"><name><surname>Ludert</surname><given-names>Juan Ernesto</given-names></name><address><email>jludert@cinvestav.mx</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="editor"><name><surname>Pujol</surname><given-names>Flor H.</given-names></name><address><email>fhpujol@ivic.gob.ve</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="editor"><name><surname>Arbiza</surname><given-names>Juan</given-names></name><address><email>jrarbiza@gmail.com</email></address><xref ref-type="aff" rid="Aff3">3</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.418275.d</institution-id><institution-id institution-id-type="ISNI">0000 0001 2165 8782</institution-id><institution>Instituto Polit&#x000e9;cnico Nacional, </institution><institution>Center for Research and Advances Studies, </institution></institution-wrap>Mexico City, Mexico </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2181 3287</institution-id><institution-id institution-id-type="GRID">grid.418243.8</institution-id><institution>Centro de Microbiologia y Biologia Celular, </institution><institution>Instituto Venezolano de Investigaciones Cient&#x000ed;ficas (IVIC), </institution></institution-wrap>Caracas, Venezuela </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000000121657640</institution-id><institution-id institution-id-type="GRID">grid.11630.35</institution-id><institution>Facultad de Ciencias, </institution><institution>Universidad de la Republica, </institution></institution-wrap>Montevideo, Uruguay </aff></contrib-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Durigon</surname><given-names>Edison Luiz</given-names></name><address><email>eldurigo@usp.br</email></address><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Botosso</surname><given-names>Viviane Fongaro</given-names></name><address><email>viviane.botosso@butantan.gov.br</email></address><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>de Oliveira</surname><given-names>Danielle Bruna Leal</given-names></name><address><email>danibruna@gmail.com</email></address><xref ref-type="aff" rid="Aff4">4</xref></contrib><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1937 0722</institution-id><institution-id institution-id-type="GRID">grid.11899.38</institution-id><institution>Laboratory of Molecular and Clinical Virology, Department of Microbiology, </institution><institution>Institute of Biomedical Sciences, University of S&#x000e3;o Paulo, </institution></institution-wrap>S&#x000e3;o Paulo, Brazil </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 1702 8585</institution-id><institution-id institution-id-type="GRID">grid.418514.d</institution-id><institution>Scientific Development Division, Virology Branch, </institution><institution>Institute Butantan, </institution></institution-wrap>S&#x000e3;o Paulo, Brazil </aff></contrib-group><pub-date pub-type="epub"><day>21</day><month>06</month><year>2017</year></pub-date><fpage>235</fpage><lpage>254</lpage><permissions><copyright-statement>&#x000a9; Springer International Publishing AG 2017</copyright-statement><license><license-p>This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">According to the World Health Organization, acute lower respiratory tract infection (ALRI) is the fourth leading cause of death worldwide, responsible for approximately 3.1 million (5.5%) of the 56 million estimated deaths per year. Human respiratory syncytial virus (RSV) is recognized as the most important cause of ALRI in infants worldwide. It is estimated that every year 33.8 million new cases of RSV-related ALRIs occur and cause approximately 200,000 deaths in children younger than 5 years; of note, 99% of these deaths occur in developing countries. Usually primary infections occur during the first 2 years of life and are symptomatic, causing from mild upper respiratory tract illness to severe ALRI, and in some cases pneumonia and bronchiolitis may occur simultaneously. Recurrent infections throughout life are common but normally cause milder upper respiratory tract illness. Several studies also associated severe RSV infections during infancy with permanent lung function reduction in adulthood, with higher risk of asthma. The seasonality of the virus varies but it is often detected throughout the year. In South America the highest incidence occurs in the months of January to June. Despite the clinical importance and the disease burden associated with RSV, there is neither specific treatment nor vaccines widely accepted and available nowadays.</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>HRSV</kwd><kwd>Respiratory syncytial virus</kwd><kwd>Respiratory viruses</kwd><kwd>Molecular diagnostic</kwd><kwd>Molecular epidemiology</kwd><kwd>Virus replication</kwd><kwd>HRSV genotype</kwd><kwd>Virus resistance</kwd><kwd>Palivizumab</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer International Publishing AG 2017</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par2">Acute respiratory infections ( ARIs)
are the most frequent infectious disease in humans, and the great majority of respiratory infections observed
in medical practice around the world are of viral etiology [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR80">80</xref>]. During the period of 2000 to 2003, an estimate of 10,600,000 children under the age of 5 years died every year, and ARIs were responsible for nearly 19% of these deaths. Most of these fatalities were caused by bronchitis and pneumonia associated with viral infections [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR57">57</xref>, <xref ref-type="bibr" rid="CR106">106</xref>, <xref ref-type="bibr" rid="CR119">119</xref>]. Viral respiratory infections are also associated with high morbidity in this age group worldwide. For example, 35% of hospitalized children in Brazil, 35% in Belgium, 22% in Italy, and 59% in the UK attending pediatric services were the result of viral respiratory infections [<xref ref-type="bibr" rid="CR78">78</xref>, <xref ref-type="bibr" rid="CR84">84</xref>, <xref ref-type="bibr" rid="CR85">85</xref>, <xref ref-type="bibr" rid="CR87">87</xref>, <xref ref-type="bibr" rid="CR98">98</xref>].</p><p id="Par3">Currently, the following viruses shall be considered causes of acute respiratory illness in children: human respiratory syncytial virus (HRSV); parainfluenza virus types 1, 2, 3, and 4 (PIV1, PIV2, PIV3, PIV4); influenza virus types A, B, C (IA, IB, IC); adenoviruses (ADV); coronaviruses HCoV-OC43, HCoV-229E, HCoV-HKU1, and HCoV-NL64; human rhinovirus (HRV); some subtypes of enterovirus (HEV-68); human metapneumovirus (hMPV); human bocavirus (HBoV); and WU and KI polyomavirus (Fig. <xref rid="Fig1" ref-type="fig">12.1</xref>). However, some viruses present high rates of co-detection, as is the case of rhinovirus, enterovirus, human coronavirus and bocavirus, and polyomavirus, being questioned for its significance in the etiology of these infections [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR49">49</xref>, <xref ref-type="bibr" rid="CR64">64</xref>, <xref ref-type="bibr" rid="CR89">89</xref>, <xref ref-type="bibr" rid="CR91">91</xref>, <xref ref-type="bibr" rid="CR96">96</xref>, <xref ref-type="bibr" rid="CR114">114</xref>].<fig id="Fig1"><label>Fig. 12.1</label><caption><p>Clinical association with major symptoms of disease and respiratory viruses. In South America, studies conducted in different regions of the country indicate the importance of viruses as etiological agents of low respiratory infection (LRI). These studies revealed the presence of different respiratory viruses in children and adults, such as human respiratory syncytial virus (HRSV), influenza A and B, HPIV, HAdV, HRV, hMPV, hBoV, and HCoV; the percentage of cases among children for some type of respiratory viruses ranged between 28.75% and 75%, whereas positivity in adults was 61.8% for at least one of the viruses studied [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR85">85</xref>, <xref ref-type="bibr" rid="CR105">105</xref>, <xref ref-type="bibr" rid="CR111">111</xref>, <xref ref-type="bibr" rid="CR116">116</xref>]</p></caption><graphic xlink:href="395178_1_En_12_Fig1_HTML" id="MO1"/></fig>
</p><p id="Par4">The seasonality of respiratory viruses is described in several studies, with some viral infections
taking place throughout the year, such as influenza virus, with a predominance in the winter months [<xref ref-type="bibr" rid="CR96">96</xref>], and others occurring chiefly in the late fall, winter, or early spring, such as HPIV, hMPV, HCoV, and HRSV [<xref ref-type="bibr" rid="CR85">85</xref>, <xref ref-type="bibr" rid="CR99">99</xref>, <xref ref-type="bibr" rid="CR105">105</xref>, <xref ref-type="bibr" rid="CR114">114</xref>]. Adenoviruses are found worldwide and can circulate sporadically, endemically, or epidemically in the winter, spring, and early summer [<xref ref-type="bibr" rid="CR103">103</xref>, <xref ref-type="bibr" rid="CR105">105</xref>].</p><p id="Par5">Despite the great number of viral agents involved in respiratory infections and their importance, the HRSV is the leading cause of acute respiratory infections and one of the leading causes of hospitalization and death among children under 5 years of age worldwide. Each year, respiratory syncytial virus (RSV) infections lead to 2,100,000 outpatient attendances and 57,257 hospitalizations of children less than 5 years of age in the U.S. Additionally, RSV is responsible for 177,000 hospitalizations with 14,000 deaths among adults over 65 years of age [<xref ref-type="bibr" rid="CR24">24</xref>].</p><p id="Par6">Newborns, premature infants, and those with chronic lung disease are at greater risk of developing severe disease by infection with HRSV [<xref ref-type="bibr" rid="CR48">48</xref>]. Despite their importance, there is no vaccine prophylaxis against HRSV infection or effective antiviral therapy available. Currently, in Latin America, only palivizumab (Pz) (Synagis; MedImmune, Gaithersburg, MD, USA) is being used in the prophylaxis and therapy of these infections [<xref ref-type="bibr" rid="CR68">68</xref>].</p></sec><sec id="Sec2"><title> History of the&#x000a0;HRSV</title><p id="Par7">In 1955, an outbreak of respiratory illness characterized by coughing, sneezing, and mucopurulent discharge was described in a colony of 20 chimpanzees at the Walter Reed Army Institute of Research (WRAIR) (Washington, DC, USA). During that episode, the RSV was isolated
for the first time from a swab from the throat of a female chimpanzee and then called the chimpanzee coryza agent ( CCA)
[<xref ref-type="bibr" rid="CR82">82</xref>]. Viral isolation was performed in liver cells, later being inoculated in various laboratory animals, mice, hamsters, rabbits, rats, and chimpanzees, the latter being the only ones to develop specific symptoms.</p><p id="Par8">One of the attendants of the chimpanzees became sick and developed symptoms similar to those of the animals. Although the attempt at isolation of human respiratory syncytial virus was unsuccessful, an increase in antibody titer by complement fixation against CCA was detected. Parallel seroprevalence studies conducted in a human general population revealed the presence of antibodies to a new CCA agent in teenagers and adults.</p><p id="Par9">The following year, Chanock and colleagues isolated a virus similar to the CCA of a child with pneumonia and another with croup, in Baltimore [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR26">26</xref>]. The agent was named human respiratory syncytial virus, HRSV, to reflect its ability to form syncytia in cell culture and its tropism for the human respiratory tract.</p><p id="Par10">Serological studies carried out at the time indicated that the majority of children in Baltimore had been infected with HRSV before 4 years of age. Similar investigations in diverse parts of the world indicated that the HRSV was associated with diseases of the lower respiratory tract [<xref ref-type="bibr" rid="CR33">33</xref>]. Currently, HRSV is recognized as the viral agent more frequently related to cases of bronchiolitis and pneumonia during infancy and preschool age. About 95% of the children have the first HRSV infection in the first 2 years of life, and the peak incidence
occurs in the first few months [<xref ref-type="bibr" rid="CR3">3</xref>]. Approximately 40% of children develop symptoms of lower respiratory tract involvement during the first infection. Although reinfections are common during a lifetime, the clinical symptoms in older children and adults are less severe [<xref ref-type="bibr" rid="CR55">55</xref>].</p><p id="Par11">Some groups of patients are at risk of developing serious illness resulting from the lower respiratory tract infection by HRSV; these include children younger than 6 months of age, premature infants, immunodeficient children, and children with chronic lung disease or congenital heart disease [<xref ref-type="bibr" rid="CR33">33</xref>]. There are also studies relating the HRSV to severe infections in the elderly [<xref ref-type="bibr" rid="CR44">44</xref>, <xref ref-type="bibr" rid="CR117">117</xref>].</p></sec><sec id="Sec3"><title> Classification</title><p id="Par12">The human respiratory syncytial virus (HRSV) is a member of the order <italic>Mononegavirales</italic> (mono, from Greek, meaning &#x0201c;single, simple&#x0201d;; nega, from Latin, meaning &#x0201c;RNA negative polarity&#x0201d;; virales, from Latin, meaning virus), classified within the <italic>Pneumoviridae</italic> family and the genus <italic>Orthopneumovirus</italic>. Other members of the <italic>Orthopneumovirus</italic> genus are the bovine respiratory syncytial virus (BRSV) and the pneumonia virus of mice (murine pneumonia virus) [<xref ref-type="bibr" rid="CR125">125</xref>].</p></sec><sec id="Sec4"><title> Structure</title><p id="Par13">The virion is pleomorphic with a diameter of 150&#x02013;300 nm and is composed of an internal nucleocapsid of helical symmetry and an envelope derived from the host cytoplasmic membrane; viral glycoproteins that protrude from the envelope as 11- to 20-nm projections, separated by intervals of 6&#x02013;10 nm, are involved in the processes of adherence and penetration of the virus. The viral genome is composed of a single-stranded RNA molecule, not segmented, and with negative polarity. Each infectious particle contains only one functional copy of the genome (Fig. <xref rid="Fig2" ref-type="fig">12.2</xref>) [<xref ref-type="bibr" rid="CR33">33</xref>].<fig id="Fig2"><label>Fig. 12.2</label><caption><p>Human respiratory syncytial virus (HRSV) virion structure
</p></caption><graphic xlink:href="395178_1_En_12_Fig2_HTML" id="MO2"/></fig>
</p></sec><sec id="Sec5"><title> Genomic Organization</title><p id="Par14">The virus contains a single-stranded negative-sense RNA genome with 15,222 nucleotides (nt), with molecular weight of 5 &#x000d7; 10<sup>6</sup> Da, which serves as a template for transcription of messenger RNAs (mRNAs), encoding for 11 proteins. The genome transcription takes place in the 5&#x02032; &#x02192; 3&#x02032; direction. The 3&#x02032;-region of the genomic RNA consists of a region of 44 nucleotides that presumably contains the viral promoter [<xref ref-type="bibr" rid="CR81">81</xref>]. The first 30 nt in this region are highly susceptible to inactivation
by the insertion or deletion of nucleotides. This region is followed by 10 genes that encode 11 proteins, in the following order: <italic>NS1</italic>, <italic>NS2</italic>, <italic>N</italic>, <italic>P</italic>, <italic>M</italic>, <italic>SH</italic>, <italic>G</italic>, <italic>F</italic>, <italic>M2</italic>,&#x000a0;<italic>L</italic>. The last gene, <italic>L</italic>, is followed by a region that is more tolerant to the insertion or deletion of nucleotides [<xref ref-type="bibr" rid="CR81">81</xref>].</p><p id="Par15">The first nine genes are separated by inter-gene regions ranging from 1 to 52 nt in size, which apparently do not have an important role in the modulation of gene expression and show little conservation among isolates [<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR71">71</xref>]. The beginning of each gene contains a conserved signal (gene start signal) composed of nine nucleotides, 3&#x02032;-CCCCGUUUA, except for the <italic>L</italic> gene, which presents the following differences as underlined: 3&#x02032;-<italic>CCCUGUUUUA</italic>. The genes end with a semi-conserved sign (gene end signal) composed of 12 or 13 nucleotides whose sequence is 3&#x02032;-UCAAUNAAAUUU, which drives the end of transcription and polyadenylation. The last two genes, <italic>M2</italic> and <italic>L</italic>, have in common 68 nt. Consequently, the gene <italic>L</italic> has the initiation of the transcript inside the M2 gene [<xref ref-type="bibr" rid="CR33">33</xref>]. The M2 has two ORFs (open reading frames), which give rise to proteins M2-1 and M2-2. The organization of the gene of HRSV is schematized in Fig. <xref rid="Fig3" ref-type="fig">12.3</xref>.<fig id="Fig3"><label>Fig. 12.3</label><caption><p>Organization of the gene in the genome of HRSV. The genome is 15,225 nucleotides long, a single-stranded RNA with negative polarity. It has 10 genes encoding 11 proteins . The <italic>M2</italic> gene has two products: a nucleocapsid-associated transcription factor (M2-1) and another protein involved in genome replication (M2-2)</p></caption><graphic xlink:href="395178_1_En_12_Fig3_HTML" id="MO3"/></fig>
</p></sec><sec id="Sec6"><title> Proteins</title><p id="Par16">In cells infected with HRSV, 11 proteins have been identified. Of these, 2 are nonstructural proteins, NS1 and NS2, present in abundance in the cells, but in small amounts in the virion. The others are structural proteins, M (matrix) and M2-1(transcriptiol elongation factor) proteins, N (nucleoprotein), P (phosphoprotein), L (large polymerase), and M22 nucleocapsid viral proteins, and 3 are surface glycoproteins G (attachment), F (fusion), and SH (small hydrophobic) [<xref ref-type="bibr" rid="CR33">33</xref>]. The glycoproteins F and G are highly accessible to neutralizing antibodies, resulting in numerous changes
in response to the host immune pressure [<xref ref-type="bibr" rid="CR34">34</xref>] and therefore are the most studied.</p><p id="Par17">The NS1 (molecular weight PM, 15.5 kDa) and NS2 (PM, 27 kDa) proteins have, respectively, 139 and 124 amino acids, and the genes that encode these have 532 and 503 nucleotides, respectively. Their functions are not well understood, but it is presumed that they are related to the structural regulation of RNA synthesis, the morphogenesis of the virion, or the interaction with the host cells [<xref ref-type="bibr" rid="CR33">33</xref>].</p><p id="Par18">The proteins P, L, and N are associated with genomic RNA and nucleocapsid, forming the ribonucleoprotein complex, considered as the minimum unit necessary for transcription and replication of the virus. The P protein is highly phosphorylated and acidic and has a key role in the regulation of the transcription and replication process. It has 241 amino acids and a molecular weight of 35 kDa, and the gene that encodes it has 914 nucleotides. The nucleoprotein N has 391 amino acids and a molecular weight of 43.4 kDa, and the gene that encodes it has 1203 nucleotides and is the main structural protein of the nucleocapsid, closely associated with the genomic RNA. The L protein, consisting of 2165 amino acids with a molecular weight of 250 kDa, is the largest viral protein. The gene that encodes the L protein has 6578 nucleotides [<xref ref-type="bibr" rid="CR33">33</xref>].</p><p id="Par19">The M proteins (PM, 27 kDa) and M2-1 (PM, 22 kDa) are internal and not glycosylated, possessing, respectively, 194 and 256 amino acids, and the genes that encode them have 958 and 961 nucleotides, respectively. The M protein mediates the association of nucleocapsid with the viral envelope [<xref ref-type="bibr" rid="CR33">33</xref>], and the M2-1 acts on the elongation during transcription [<xref ref-type="bibr" rid="CR32">32</xref>].</p><p id="Par20">The SH protein is a small molecule (amino acids and 64 PM, 7.5 kDa), which is inserted in the cytoplasmic membrane of the host cell via a hydrophobic sequence, ranging from 14 to 41 amino acids. The function of this protein has not yet been clarified
; however, because it is integrated in the membrane, it is assumed to be involved in adsorption, penetration, and denudation of the virus [<xref ref-type="bibr" rid="CR33">33</xref>].</p><p id="Par21">The glycoprotein F has 574 amino acids with a molecular weight of 70 kDa, and the gene that encodes it has 1903 nucleotides. Identified as a fusion protein, it is responsible for the attachment of the viral envelope with the plasma membrane of the host cell, releasing nucleocapsid directly within the cytoplasm. Also, it is responsible for the fusion of the cell infected with neighbor cells, favoring the formation of the syncytium [<xref ref-type="bibr" rid="CR33">33</xref>].</p><p id="Par22">The F protein is synthesized as an inactive precursor called F0, which consists of two domains, F2 (1&#x02013;130 amino acids) and F1 (137&#x02013;574 amino acids), and also has a cleaved peptide (131&#x02013;136 amino acids). The F1 subunit is anchored to the membrane. The F1 subunit is relatively well preserved and is greatly affected in its function by deletions or substitutions of amino acids [<xref ref-type="bibr" rid="CR33">33</xref>].</p><p id="Par23">The glycoprotein G is a type II protein, which is anchored to the membrane next to its amino-terminal portion by a hydrophobic domain, non-cleaved, signal anchor type, that extends from residues 38 to 66 [<xref ref-type="bibr" rid="CR73">73</xref>]. The G protein is 289 to 342 amino acids in length, depending on the viral strain. The G gene is composed of 918 to 1062 (group A) or 921 to 981 (group B) nucleotides [<xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR102">102</xref>, <xref ref-type="bibr" rid="CR108">108</xref>].</p><p id="Par24">The glycoprotein G is the viral attachment engaged in the adsorption of virus, and it has been shown that antibodies against the G glycoprotein inhibited the binding of virus to the cells [<xref ref-type="bibr" rid="CR72">72</xref>]. The glycoprotein G is of special interest for showing the largest variability between the viral isolates [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR52">52</xref>, <xref ref-type="bibr" rid="CR67">67</xref>] and can support large deletions or multiple amino acid substitutions without loss of function [<xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR102">102</xref>]. This variability among strains of HRSV is a signature feature that can alter the pathogenicity and adaptation of the virus and contribute to the ability of the virus to cause repeated infections and outbreaks by escaping
the immune system. The glycoproteins F and G are the most important proteins involved in a protective immune response [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR66">66</xref>], and antibodies against them show strong neutralization activity in vitro [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR123">123</xref>].</p></sec><sec id="Sec7"><title>Replication </title><p id="Par25">The cell receptor specific for the glycoprotein G was first identified by Krusat and Streckert [<xref ref-type="bibr" rid="CR70">70</xref>], who showed that preincubation of the virus with heparin inhibited the infection in cell culture and that the G protein binds heparin. These results suggest that heparin or other glycosaminoglycans (GAGs) similar to heparin, present on the cell surface, are involved in the binding of the virus to the cell. The binding site of the glycoprotein G to the heparin (or another GAG) was mapped between the 184 and 198 amino acids of the protein G for group A and among the 183 to 197 amino acids for group B. Martinez et al. [<xref ref-type="bibr" rid="CR77">77</xref>] confirmed that the presence of these receptors is critical for the binding of the virus.</p><p id="Par26">The virus enters into the cell through fusion with the cell membrane. After penetration, the viral envelope remains as part of the cell membrane. The nucleocapsid is released into the cytoplasm and begins the process of transcription of the viral genome by the viral polymerase. The genes are transcribed in sense 3&#x02032; &#x02192; 5&#x02032; with a sign promoting to the 3&#x02032;-side [<xref ref-type="bibr" rid="CR33">33</xref>]. The peak of the synthesis of mRNAs occurs 16 h after infection, and the peak of proteins occurs at 18&#x02013;20 h [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR33">33</xref>]. In addition to the transcription and translation of proteins, another important step is the replication of the viral genome, which produces an intermediate positive (+ ssRNA), which will serve as a template to generate more copies of the viral genome (ssRNA). All the replication process takes place in the cytoplasm [<xref ref-type="bibr" rid="CR33">33</xref>].</p><p id="Par27">The maturation of the virus occurs in the first instance, with the combination of proteins N and P to the genomic RNA and subsequent addition of other auxiliary proteins to the nucleocapsid. The surface glycoproteins are inserted into the cytoplasmic membrane of the host cell . In the next step the matrix protein interacts by noncovalent forces to the cytoplasmic tails of the surface glycoprotein. The assembled internal structures of the virus interact with this surface and drive the budding, with the release of the virus, when the virus acquires the lipoprotein envelope [<xref ref-type="bibr" rid="CR69">69</xref>].</p></sec><sec id="Sec8"><title> Genetic Variability</title><p id="Par28">The variability of the G protein is concentrated in the extracellular domain, where two variable regions have a high content of serine and threonine, between 69 to 164 and 207 to 298 amino acids
, with approximately 56% divergence between groups A and B [<xref ref-type="bibr" rid="CR66">66</xref>, <xref ref-type="bibr" rid="CR67">67</xref>]. Interspersing this region of high variability, there is a conserved region with a small segment of 13 amino acids (164&#x02013;176) and four cysteine residues (C173, C176, C182, C186), which are well preserved in all samples of HRSV [<xref ref-type="bibr" rid="CR97">97</xref>, <xref ref-type="bibr" rid="CR118">118</xref>], suggesting that this region is responsible for binding the virus to a cell receptor. However, data about the region for genotypes that emerged after 2010 are currently lacking.</p><p id="Par29">The genotyping of HRSV-A and HRSV-B is based on the variability of the G-protein gene. For HRSV A, 11 genotypes were reported and designated as GA1, GA2, GA3, GA4, GA5, GA6, and GA7 [<xref ref-type="bibr" rid="CR92">92</xref>, <xref ref-type="bibr" rid="CR93">93</xref>], SAA1 (South Africa, A1) [<xref ref-type="bibr" rid="CR115">115</xref>], and more recently, NA1, NA2, NA3, and NA4 [<xref ref-type="bibr" rid="CR102">102</xref>]. For HRSV-B, 17 genotypes have been described and designated as GB1, GB2, GB3, and GB4 [<xref ref-type="bibr" rid="CR93">93</xref>], SAB1, SAB3 [<xref ref-type="bibr" rid="CR115">115</xref>], BA1&#x02013;BA6 (Argentina) [<xref ref-type="bibr" rid="CR109">109</xref>], BA7&#x02013;BA10 (Japan) [<xref ref-type="bibr" rid="CR38">38</xref>], and B11 (Korea) [<xref ref-type="bibr" rid="CR7">7</xref>]. Interestingly, strains belonging to genotype BA of HRSV-B exhibited duplication of 60 nucleotides (nt) in the second variable region protein gene <italic>G</italic>, but were not associated with more severe clinical manifestations [<xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR108">108</xref>]. In Brazil, the only genotypes circulating currently from HRSV-A are NA2, NA3, and ON1 and BA genotyping from HRSV-B.</p><p id="Par30">In 2012, Eshaghi et al. [<xref ref-type="bibr" rid="CR43">43</xref>] detected in group A one repetition of 72 nucleotides (GTCAAGAGGAAACCCTCCACTCAACCACCTCCGAAG GCTATCTAAGCCCATCACAAGTCTATACAACATCCG) in the C-terminal portion of the gene (G), being the largest duplication described in this group. This new genotype was called ON1 and was found in 10% of HRSV isolates. In 2013 this ON1 genotype was found in 75% of all isolates in Brazil [<xref ref-type="bibr" rid="CR42">42</xref>, <xref ref-type="bibr" rid="CR80">80</xref>], and in 2015 the ON1 genotype had attained natural dominance and become the predominant genotype circulating in different areas of the world [<xref ref-type="bibr" rid="CR107">107</xref>]. This area is specifically targeted for neutralizing antibodies, and these types of changes of structure can lead to changes in immunogenicity
and pathogenicity of the virus. However, additional studies are still required to explore the pathogenicity, transmissibility, and replication of this new variant .</p></sec><sec id="Sec9"><title> Epidemiology</title><p id="Par31">In the 1990s several studies of molecular epidemiology were conducted based on partial sequences of genes <italic>G</italic> and <italic>SH</italic> and a restriction map of the <italic>N</italic> gene, enabling reaching some important conclusions about HRSV circulation:<list list-type="order"><list-item><p id="Par32">The existence of several genotypes circulating concurrently in a single outbreak, with a predominance of one or two genotypes which tend to decrease in subsequent outbreaks until its disappearance [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR65">65</xref>, <xref ref-type="bibr" rid="CR75">75</xref>, <xref ref-type="bibr" rid="CR92">92</xref>, <xref ref-type="bibr" rid="CR93">93</xref>].</p></list-item><list-item><p id="Par33">The genotypes of HRSV have worldwide distribution, and strains isolated in distinct communities and in different years may be more related to strains isolated in the same locality in two consecutive days, demonstrating a pattern of temporal and not necessarily geographic circulation [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR50">50</xref>].</p></list-item><list-item><p id="Par34">Within each strain (genotype) occurs a progressive buildup of amino acid changes [<xref ref-type="bibr" rid="CR21">21</xref>].</p></list-item><list-item><p id="Par35">Antigenic changes detected with a panel of anti-G monoclonal antibodies can be correlated with the position of the viruses in the phylogenetic trees [<xref ref-type="bibr" rid="CR50">50</xref>].</p></list-item><list-item><p id="Par36">The synonymous nucleotide substitutions have a uniform distribution over the <italic>G</italic> gene, and non-synonymous substitutions are accumulated in the two variable regions of the gene <italic>G</italic> [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR50">50</xref>].</p></list-item></list>
</p><p id="Par37">However, there are studies in which a minimal temporal variation in the gene encoding the G protein has been reported. A study performed in Cuba revealed the movement of extremely homogeneous samples during the 1994&#x02013;1995 outbreaks, with a difference of just five nucleotides
when compared to the sample long since isolated in 1956 [<xref ref-type="bibr" rid="CR113">113</xref>].</p><p id="Par38">The significance of the antigenic variation of HRSV groups in epidemiology is not yet clear. The antigenic dimorphism, although at modest rates, seems to contribute to the high incidence of reinfections during the first years of life. However, several reinfections in children involving viruses of the same group have been reported [<xref ref-type="bibr" rid="CR60">60</xref>, <xref ref-type="bibr" rid="CR83">83</xref>]. In addition, there is no indication that reinfection with a heterologous group induces more serious clinical signs than reinfection with homologous samples [<xref ref-type="bibr" rid="CR110">110</xref>].</p><p id="Par39">The two groups (A and B) have been circulating concurrently in many epidemics for more than 20 years [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR65">65</xref>], in diverse regions of the world, and with incidences that vary from year to year. Studies conducted in El Salvador, Santa Fe, and Buenos Aires in Argentina revealed the presence of both groups during outbreaks with prevalence of group A [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR63">63</xref>, <xref ref-type="bibr" rid="CR121">121</xref>].</p><p id="Par40">In some localities , such as Rochester and Boston in the U.S., Sapporo in Japan, and Rio de Janeiro, Porto Alegre, and Ribeir&#x000e3;o Preto in Brazil, in addition to the co-circulation of the groups, the prevalence of groups A and B may switch over the years or show a balance of the frequencies of both groups [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR56">56</xref>, <xref ref-type="bibr" rid="CR58">58</xref>, <xref ref-type="bibr" rid="CR104">104</xref>, <xref ref-type="bibr" rid="CR112">112</xref>].</p><p id="Par41">Differences in pathogenicity between the two groups are not clear. Hall et al. [<xref ref-type="bibr" rid="CR56">56</xref>] and Imaz et al. [<xref ref-type="bibr" rid="CR63">63</xref>] verified increased severity in children infected with group A, although Zelaya et al. [<xref ref-type="bibr" rid="CR121">121</xref>] found greater severity in children infected with group B. Other authors did not observe significant differences in pathogenicity between the groups [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR104">104</xref>].</p><p id="Par42">In a study carried out in Bogota, Colombia, a total of 13,488 samples of children hospitalized with a diagnosis of respiratory infection were tested for RSV during 5 years and 4,559 (33.8%) were found positive. The average age of patients analyzed in the study was 9.2 &#x000b1; 8.5 months, and 71.7% of cases of HRSV infection occurred in the period from March to May, whereas 50% of the bronchiolitis cases were diagnosed from April to June during the years of the study [<xref ref-type="bibr" rid="CR47">47</xref>].</p><p id="Par43">In Chile, HRSV are detected as a single pathogen at 74/124 (58.7%) samples of nasopharyngeal aspirate of patients, and 28/124 (22.6%) samples were co-detected with HRV. Hospitalization was necessary in 77% of positive cases of HRSV (57/74), and 44.6% of these cases were considered serious; 53.6% (15/28) of cases coinfected by both viruses were hospitalized, too, but this coinfection does not increase the severity of illness [<xref ref-type="bibr" rid="CR74">74</xref>].</p><p id="Par44">In Brazil, many studies have already been carried out to investigate the etiology of acute respiratory diseases [<xref ref-type="bibr" rid="CR12">12</xref>]. During the period of 2003&#x02013;2009, nasopharyngeal aspirates were examined in more than 2000 children less than 5 years old, and HRSV were found in at least 42% of positivity between respiratory viruses identified in children
hospitalized with acute respiratory disease [<xref ref-type="bibr" rid="CR85">85</xref>, <xref ref-type="bibr" rid="CR105">105</xref>].</p><p id="Par45">In countries in southern Latin America such as Argentina and Uruguay, outbreaks of HRSV occur predominantly during the winter months [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR61">61</xref>]. In tropical and subtropical climates , the outbreaks are not always well defined, although in Ceara, located in the northeast of Brazil, HRSV caused yearly seasonal epidemics, generally from February until July (Moura et al. 2013). In Brazil, in the cities of Rio de Janeiro and S&#x000e3;o Paulo, HRSV outbreaks start in autumn (ranging from March to April) and extend until winter (July&#x02013;August), with peak incidence occurring usually in May (Table <xref rid="Tab1" ref-type="table">12.1</xref>) [<xref ref-type="bibr" rid="CR85">85</xref>, <xref ref-type="bibr" rid="CR105">105</xref>].<table-wrap id="Tab1"><label>Table 12.1</label><caption><p>Occurrence of positivity for human respiratory syncytial virus (HRSV) in different cities of Latin America at different times of the year
</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Country</th><th>City</th><th>Seasonality</th><th>Average of HRSV positive (%)</th></tr></thead><tbody><tr><td>Argentina</td><td>Buenos Aires</td><td>Autumn&#x000a0;&#x02013; winter</td><td>23&#x02013;26</td></tr><tr><td rowspan="2">Brazil</td><td>Tropical</td><td>Summer&#x000a0;&#x02013; winter</td><td>21&#x02013;4</td></tr><tr><td>Subtropical</td><td>Autumn&#x000a0;&#x02013; winter</td><td>42</td></tr><tr><td>Chile</td><td>Santiago</td><td>Winter</td><td>22.6&#x02013;52.7</td></tr><tr><td rowspan="2">Colombia</td><td>Cali</td><td>Throughout the year</td><td>33.8</td></tr><tr><td>Medell&#x000ed;n</td><td>Summer</td><td>41.7</td></tr><tr><td>Costa Rica</td><td>San Jose</td><td>Autumn</td><td>15&#x02013;20</td></tr><tr><td rowspan="2">Mexico</td><td>Mexico City</td><td>Winter&#x000a0;&#x02013; spring</td><td>36&#x02013;55</td></tr><tr><td>San Luis Potos&#x000ed;</td><td>Autumn&#x000a0;&#x02013; winter</td><td>24.8&#x02013;46.7</td></tr><tr><td>Venezuela</td><td>Caracas</td><td>Throughout the year</td><td>31.6&#x02013;66</td></tr><tr><td>Uruguay</td><td>Montevideo</td><td>Winter</td><td>56</td></tr><tr><td>Guatemala</td><td>Santa Rosa and Quetzaltenango</td><td>Autumn</td><td>24</td></tr></tbody></table></table-wrap>
</p><p id="Par46">Fortunately, fatalities from infection by HRSV are uncommon, and estimates indicate that the number of deaths is around 200&#x02013;500 a year, 80% of which are of children under 1 year of age. However, mortality may increase significantly in children who present some background that predisposes to more serious diseases, such as congenital heart diseases and lung diseases
, and premature infants, in which mortality by HRSV infection is around 10%, 5.5%, and 4.6%, respectively [<xref ref-type="bibr" rid="CR41">41</xref>, <xref ref-type="bibr" rid="CR100">100</xref>]. High mortality rates may also be observed in individuals with immunodeficiency, congenital or induced by chemotherapy against cancer [<xref ref-type="bibr" rid="CR54">54</xref>] or from organ transplants, especially in the first 20 days after the transplant [<xref ref-type="bibr" rid="CR94">94</xref>]. Among bone marrow transplant recipients, the mortality of those who become infected with HRSV can reach 45% [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR57">57</xref>].</p><p id="Par47">A study conducted in the U.S. revealed the occurrence of 14,000 to 62,000 annual hospitalizations of the elderly with pneumonia associated with HRSV, at a cost of approximately 150,000,000&#x02013;680,000,000 dollars to the health system and causing about 1,500&#x02013;6,700 deaths per year (5&#x02013;20 deaths/100,000) [<xref ref-type="bibr" rid="CR124">124</xref>].</p></sec><sec id="Sec10"><title> Laboratory Diagnosis</title><p id="Par48">The laboratory diagnosis of HRSV can be carried out by the direct detection of viruses, viral antigens, or the viral genome or, indirectly, based on the detection of specific antibodies. For the routine clinical laboratory diagnosis using respiratory secretions as biological samples, the procedures may include viral isolation in cell culture, antigen detection by immunofluorescence or enzyme-linked immunosorbent assay, and viral RNA detection by reverse transcriptase (RT)-polymerase chain reaction (PCR). The best samples are those obtained by aspiration or washing nasopharyngeal secretions [<xref ref-type="bibr" rid="CR76">76</xref>, <xref ref-type="bibr" rid="CR79">79</xref>]. The viral particle present in the secretions is highly labile, and the samples should be kept refrigerated during transportation to the laboratory and processing before inoculation in cell cultures
.</p><p id="Par49">The isolation in cell culture , regarded as the gold standard, can be carried out in a wide variety of human and animal cell lines, but HEp-2 and HeLa cells are the most used [<xref ref-type="bibr" rid="CR110">110</xref>; Perini et al. 2007]. The cytopathic effect usually appears within 3&#x02013;7 days after inoculation and is characterized by the presence of large syncytia resulting from cell fusion (Fig. <xref rid="Fig4" ref-type="fig">12.4</xref>). Nevertheless, as viral isolation in cell culture is difficult, the diagnosis of infection is most often accomplished by detection of HRSV antigens in nasopharyngeal epithelial cells by immunofluorescence (Fig. <xref rid="Fig5" ref-type="fig">12.5</xref>) or enzyme-linked immunosorbent assay, faster methods that do not require the presence of infectious viral particles. These last two methods require the adequate preparation of the specimens by removing excess mucus. Finally, success of the immunofluorescence technique, aside from well-trained personnel and well-prepared samples, requires a minimum number of infected cells to enable a correct diagnosis [<xref ref-type="bibr" rid="CR110">110</xref>].<fig id="Fig4"><label>Fig. 12.4</label><caption><p>
Cytopathic effect of HRSV in HEp-2 cell line shows a large syncytium resulting from a fusion of the cells</p></caption><graphic xlink:href="395178_1_En_12_Fig4_HTML" id="MO4"/></fig>
<fig id="Fig5"><label>Fig. 12.5</label><caption><p>Results of the indirect immunofluorescence (IFI) assay for detection of HRSV in nasopharyngeal aspirates. <italic>Red</italic>, negative results; <italic>green</italic>, positive detection of HRSV in the cytoplasm and membrane of the cell</p></caption><graphic xlink:href="395178_1_En_12_Fig5_HTML" id="MO5"/></fig>
</p><p id="Par50">Hughes et al. [<xref ref-type="bibr" rid="CR62">62</xref>] compared the three diagnostic techniques for HRSV: isolation in cell culture , direct and indirect immunofluorescence (IFA), and enzyme-linked immunosorbent assay (ELISA). Both immunofluorescence-based methods detected more positive samples (showed higher sensitivity) than viral isolation. However, 15% of the samples found positive by viral isolation
were negative by immunofluorescence, demonstrating the need for the use of at least two diagnostic methods.</p><p id="Par51">The RT-PCR technique has been used both for the diagnosis [<xref ref-type="bibr" rid="CR51">51</xref>, <xref ref-type="bibr" rid="CR59">59</xref>, <xref ref-type="bibr" rid="CR117">117</xref>] and for typing a sample to group A or B [<xref ref-type="bibr" rid="CR53">53</xref>, <xref ref-type="bibr" rid="CR122">122</xref>]. It is considered a highly sensitive technique, especially useful in the diagnosis of infections, in which both the sample amount and the viral load in the sample are small, as is the case of samples taken from the elderly [<xref ref-type="bibr" rid="CR117">117</xref>]. In the past decade, the molecular methods were considered as a gold standard, because of their specificity and ability of simultaneous detection of different viruses [<xref ref-type="bibr" rid="CR90">90</xref>]. The advances in real time-RT-PCR (quantitative (q)RT-PCR) specificity and sensitivity for the detection of HRSV in clinical samples became more suitable for diagnosis in clinical laboratories [<xref ref-type="bibr" rid="CR46">46</xref>].</p><p id="Par52">The rapid antigen detection tests (RADTs) are dipstick-based immunoassays that allow for the rapid, qualitative detection of RSV antigen (viral fusion protein) directly from nasopharyngeal swab, nasopharyngeal aspirate, or nasal/nasopharyngeal wash specimens from symptomatic pediatric patients. The RADTs provide a result in 15 min, compared to approximately 90 min for a conventional IFA test and 2&#x02013;3 h for ELISA [<xref ref-type="bibr" rid="CR80">80</xref>]. Rapid tests may also be used as a point-of-care assay. These methods, although effective, may present several drawbacks, including price and skilled personnel. All these issues pose a challenge to hospitals and pediatric clinics to apply the best medical management for monitoring or treatment of children with suspected infection.</p><p id="Par53">Serological diagnoses can be made through neutralization assays, complement fixation, or determination of class-specific immunoglobulins (IgG, IgM) by ELISA or immunofluorescence techniques. The diagnosis is based on the increase in antibody titer between acute and convalescent titers, performed in serum or saliva [<xref ref-type="bibr" rid="CR110">110</xref>, <xref ref-type="bibr" rid="CR120">120</xref>]. The serology offers limited value in the diagnosis of primary infection in children less than 6 months of age because 40% of these cases present no increase in antibody titer. However, in infants and adults, the serology is regarded as a good indicator of reinfections [<xref ref-type="bibr" rid="CR55">55</xref>]. The serology, therefore, is not the most appropriate method for diagnosis of infection by HRSV, having, however, great importance in clinical and epidemiological studies [<xref ref-type="bibr" rid="CR36">36</xref>].</p></sec><sec id="Sec11"><title> Treatment and Prevention</title><p id="Par54">Ribavirin (1-&#x003b2;-<sc>d</sc>-ribofuranosyl-1,2,4-triazole-3-carboxamide), a nucleoside analogue of the guanosine, licensed since 1986, is the treatment of choice for RSV. Its use is indicated
in the form of aerosol for the treatment of serious diseases caused by HRSV. Although several studies have demonstrated the effectiveness of ribavirin in inhibiting replication of the virus and the improvement of clinical conditions, resulting in a decrease in the need for supplemental oxygen and mechanical ventilation in children with lower respiratory tract infection, chronic lung disease, and infection in immunocompromised individuals, lately there has been controversy about the benefits of its use. Since 1989, several studies have appeared indicating that the use of ribavirin has minimal effect on disease outcome caused by HRSV, not showing evidence of decreased duration of hospitalization or the need of supporting therapy, in addition to the high cost and extended treatment (12 h or more of inhalation) [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR37">37</xref>].</p><p id="Par55">Several drug candidates have been studied in the past decades, including several inhibitors, targeting different HRSV proteins. Despite these efforts, until the present time there has been no antiviral drug approved for treatment (Heylen et al. 2017).</p><p id="Par56">Development of an RSV vaccine has been hampered by the incidence of enhanced respiratory disease (ERD) following vaccination with formalin-inactivated RSV in the 1960s. Since its failure, multiple live virus vaccines have been developed, as well as other vaccine platforms, including virus-like particles, peptide-based vaccines, protein subunit vaccines, and plasmid DNA-based vaccines. Many of these vaccines have been evaluated in animals, and a few have been studied in humans. None, however, has shown sufficient promise to move toward licensure. It is clear that a better understanding of virus and host factors that contribute to both disease and protective immunity is still necessary to develop safe and effective RSV vaccines.</p><p id="Par57">Alternative approaches to identify vaccine-relevant epitopes include the identification of neutralizing RSV protein
epitopes to which a protective immune response can be safely generated and the development of modern pre- and post-RSV fusion (F) protein subunits. One obstacle to developing an RSV vaccine has been the difficulty in inducing long-term protective immunity, as evidenced by the repeated infections throughout life and the incomplete protection afforded to recipients of immune prophylaxis. In addition, an immunogenic approach targeted to a single neutralizing epitope mapped to the site A region may generate a focused immune response against RSV F, but in general, the polyclonal response generated by site A-based vaccines has been characterized by poor binding to intact RSV F protein, modest in vitro neutralization, and no evidence of protection to RSV challenges in vivo.</p><p id="Par58">
Palivizumab (Pz) (Synagis; MedImmune) is a humanized IgG monoclonal antibody that neutralizes HRSV through interaction with the HRSV F glycoprotein. Pz is the only FDA-approved prophylaxis against HRSV infection [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR101">101</xref>]. Five monthly Pz injections spanning the annual HRSV epidemic period have been shown to reduce hospitalizations among high-risk children in the U.S. However, the quasi-species nature of RNA viruses allows rapid emergence of escape mutants to the immune pressure . The increasing use of Pz in high-risk children and immunocompromised patients provides opportunities for Pz-resistant mutants to arise and persist among humans [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR86">86</xref>, <xref ref-type="bibr" rid="CR88">88</xref>, <xref ref-type="bibr" rid="CR123">123</xref>]. However, little is known of these mutations in patients who did not use Pz.</p></sec></body><back><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>O</given-names></name><name><surname>Bonzel</surname><given-names>L</given-names></name><name><surname>Kovacevic</surname><given-names>A</given-names></name><name><surname>Mayatepek</surname><given-names>E</given-names></name><name><surname>Hoehn</surname><given-names>T</given-names></name><name><surname>Vogel</surname><given-names>M</given-names></name></person-group><article-title>Palivizumab-resistant human respiratory syncytial virus infection in infancy</article-title><source>Clin Infect Dis</source><year>2010</year><volume>51</volume><issue>2</issue><fpage>185</fpage><lpage>188</lpage><pub-id pub-id-type="doi">10.1086/653534</pub-id><?supplied-pmid 20528472?><pub-id pub-id-type="pmid">20528472</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>LJ</given-names></name><name><surname>Bingham</surname><given-names>P</given-names></name><name><surname>Hierholzer</surname><given-names>JC</given-names></name></person-group><article-title>Neutralization of respiratory syncytial virus by individual and mixtures of F and G protein monoclonal antibodies</article-title><source>J Virol</source><year>1988</year><volume>62</volume><issue>11</issue><fpage>4232</fpage><lpage>4238</lpage><?supplied-pmid 2459412?><pub-id pub-id-type="pmid">2459412</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>LJ</given-names></name><name><surname>Parker</surname><given-names>RA</given-names></name><name><surname>Strikas</surname><given-names>RL</given-names></name></person-group><article-title>Association between respiratory syncytial virus outbreaks and lower respiratory tract deaths of infants and young children</article-title><source>J Infect Dis</source><year>1990</year><volume>161</volume><issue>4</issue><fpage>640</fpage><lpage>646</lpage><pub-id pub-id-type="doi">10.1093/infdis/161.4.640</pub-id><?supplied-pmid 2319164?><pub-id pub-id-type="pmid">2319164</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>LJ</given-names></name><name><surname>Hierholzer</surname><given-names>JC</given-names></name><name><surname>Tsou</surname><given-names>C</given-names></name><name><surname>Hendry</surname><given-names>RM</given-names></name><name><surname>Fernie</surname><given-names>BF</given-names></name><name><surname>Stone</surname><given-names>Y</given-names></name><name><surname>Mcintosh</surname><given-names>K</given-names></name></person-group><article-title>Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies</article-title><source>J Infect Dis</source><year>1985</year><volume>151</volume><fpage>626</fpage><lpage>633</lpage><pub-id pub-id-type="doi">10.1093/infdis/151.4.626</pub-id><?supplied-pmid 2579169?><pub-id pub-id-type="pmid">2579169</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anon</surname></name></person-group><article-title>Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk in infants</article-title><source>Pediatrics</source><year>1998</year><volume>102</volume><fpage>531</fpage><lpage>537</lpage><pub-id pub-id-type="doi">10.1542/peds.102.3.531</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arslanagic</surname><given-names>E</given-names></name><name><surname>Matsumoto</surname><given-names>M</given-names></name><name><surname>Suzuki</surname><given-names>K</given-names></name><name><surname>Nerome</surname><given-names>K</given-names></name><name><surname>Tsutsumi</surname><given-names>H</given-names></name><name><surname>Hung</surname><given-names>T</given-names></name></person-group><article-title>Maturation of respiratory syncytial virus within HEp-2 cell cytoplasm</article-title><source>Acta Virol</source><year>1996</year><volume>40</volume><issue>4</issue><fpage>209</fpage><lpage>214</lpage><?supplied-pmid 9014011?><pub-id pub-id-type="pmid">9014011</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baek</surname><given-names>YH</given-names></name><name><surname>Choi</surname><given-names>EH</given-names></name><name><surname>Song</surname><given-names>MS</given-names></name><name><surname>Pascua</surname><given-names>PN</given-names></name><name><surname>Kwon</surname><given-names>HI</given-names></name><name><surname>Park</surname><given-names>SJ</given-names></name><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Woo</surname><given-names>SI</given-names></name><name><surname>Ahn</surname><given-names>BH</given-names></name><name><surname>Han</surname><given-names>HS</given-names></name><name><surname>Hahn</surname><given-names>YS</given-names></name><name><surname>Shin</surname><given-names>KS</given-names></name><name><surname>Jang</surname><given-names>HL</given-names></name><name><surname>Kim</surname><given-names>SY</given-names></name><name><surname>Choi</surname><given-names>YK</given-names></name></person-group><article-title>Prevalence and genetic characterization of respiratory syncytial virus (RSV) in hospitalized children in Korea</article-title><source>Arch Virol</source><year>2012</year><volume>157</volume><issue>6</issue><fpage>1039</fpage><lpage>1050</lpage><pub-id pub-id-type="doi">10.1007/s00705-012-1267-1</pub-id><?supplied-pmid 22402914?><pub-id pub-id-type="pmid">22402914</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beeler</surname><given-names>JA</given-names></name><name><surname>Coelingh van Wyke</surname><given-names>K</given-names></name></person-group><article-title>Neutralization epitopes of the F glycoprotein of respiratory syncytial virus: effect of mutation upon fusion function</article-title><source>J Virol</source><year>1989</year><volume>63</volume><fpage>2941</fpage><lpage>2950</lpage><?supplied-pmid 2470922?><pub-id pub-id-type="pmid">2470922</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boivin</surname><given-names>G</given-names></name><name><surname>Caouette</surname><given-names>G</given-names></name><name><surname>Frenette</surname><given-names>L</given-names></name><name><surname>Carbonneau</surname><given-names>J</given-names></name><name><surname>Ouakki</surname><given-names>M</given-names></name><name><surname>Serres</surname><given-names>G</given-names></name></person-group><article-title>Human respiratory syncytial virus and other viral infections in infants receiving palivizumab</article-title><source>J Clin Virol</source><year>2008</year><volume>42</volume><issue>1</issue><fpage>52</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1016/j.jcv.2007.11.012</pub-id><?supplied-pmid 18164233?><pub-id pub-id-type="pmid">18164233</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boivin</surname><given-names>G</given-names></name><name><surname>De Serres</surname><given-names>G</given-names></name><name><surname>C&#x000f4;te</surname><given-names>S</given-names></name><name><surname>Gilca</surname><given-names>R</given-names></name><name><surname>Abed</surname><given-names>Y</given-names></name><name><surname>Rochette</surname><given-names>L</given-names></name><name><surname>Bergeron</surname><given-names>MG</given-names></name><name><surname>Dery</surname><given-names>EP</given-names></name></person-group><article-title>Human metapneumov&#x000ed;rus infection in hospitalized children</article-title><source>Emerg Infect Dis</source><year>2003</year><volume>9</volume><issue>6</issue><fpage>634</fpage><lpage>640</lpage><pub-id pub-id-type="doi">10.3201/eid0906.030017</pub-id><?supplied-pmid 12781001?><pub-id pub-id-type="pmid">12781001</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonfim</surname><given-names>CM</given-names></name><name><surname>Nogueira</surname><given-names>ML</given-names></name><name><surname>Simas</surname><given-names>PV</given-names></name><name><surname>Gardinassi</surname><given-names>LG</given-names></name><name><surname>Durigon</surname><given-names>EL</given-names></name><name><surname>Rahal</surname><given-names>P</given-names></name><name><surname>Souza</surname><given-names>FP</given-names></name></person-group><article-title>Frequent respiratory pathogens of respiratory tract infections in children attending daycare centers</article-title><source>J Pediatr (Rio)</source><year>2011</year><volume>87</volume><issue>5</issue><fpage>439</fpage><lpage>444</lpage><pub-id pub-id-type="doi">10.2223/JPED.2126</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Botosso</surname><given-names>VF</given-names></name><name><surname>Zanotto</surname><given-names>PM</given-names></name><name><surname>Ueda</surname><given-names>M</given-names></name><name><surname>Arruda</surname><given-names>E</given-names></name><name><surname>Gilio</surname><given-names>AE</given-names></name><name><surname>Vieira</surname><given-names>SE</given-names></name><name><surname>Stewien</surname><given-names>KE</given-names></name><name><surname>Peret</surname><given-names>TC</given-names></name><name><surname>Jamal</surname><given-names>LF</given-names></name><name><surname>Pardini</surname><given-names>MI</given-names></name><name><surname>Pinho</surname><given-names>JR</given-names></name><name><surname>Massad</surname><given-names>E</given-names></name><name><surname>Sant'anna</surname><given-names>OA</given-names></name><name><surname>Holmes</surname><given-names>EC</given-names></name><name><surname>Durigon</surname><given-names>EL</given-names></name><collab>VGDN Consortium</collab></person-group><article-title>Positive selection results in frequent reversible amino acid replacements in the G protein gene of human respiratory syncytial virus</article-title><source>PLoS Pathog</source><year>2009</year><volume>5</volume><issue>1</issue><fpage>e1000254</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.1000254</pub-id><?supplied-pmid 19119418?><pub-id pub-id-type="pmid">19119418</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bricks</surname><given-names>LF</given-names></name></person-group><article-title>Prevention of respiratory syncytial virus infections</article-title><source>Rev Hosp Clin Fac Med SP</source><year>2000</year><volume>56</volume><fpage>79</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1590/S0041-87812001000300004</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bryce</surname><given-names>J</given-names></name><name><surname>Boschi-Pinto</surname><given-names>C</given-names></name><name><surname>Shibuya</surname><given-names>K</given-names></name><name><surname>Black</surname><given-names>RE</given-names></name></person-group><article-title>Who estimates the causes of death in children</article-title><source>Lancet</source><year>2005</year><volume>365</volume><issue>23</issue><fpage>1147</fpage><lpage>1152</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(05)71877-8</pub-id><?supplied-pmid 15794969?><pub-id pub-id-type="pmid">15794969</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bueno</surname><given-names>IA</given-names></name><name><surname>Riccetto</surname><given-names>AG</given-names></name><name><surname>Morcillo</surname><given-names>AM</given-names></name><name><surname>Arns</surname><given-names>CW</given-names></name><name><surname>Baracat</surname><given-names>EC</given-names></name></person-group><article-title>Respiratory syncytial v&#x000ed;rus, infants and intensive therapy</article-title><source>Braz J Infect Dis</source><year>2012</year><volume>16</volume><issue>1</issue><fpage>86</fpage><lpage>89</lpage><pub-id pub-id-type="doi">10.1590/S1413-86702012000100016</pub-id><?supplied-pmid 22358363?><pub-id pub-id-type="pmid">22358363</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cane</surname><given-names>PA</given-names></name></person-group><article-title>Molecular epidemiology of respiratory syncytial virus</article-title><source>Rev Med Virol</source><year>2001</year><volume>11</volume><fpage>103</fpage><lpage>116</lpage><pub-id pub-id-type="doi">10.1002/rmv.305</pub-id><?supplied-pmid 11262529?><pub-id pub-id-type="pmid">11262529</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cane</surname><given-names>PA</given-names></name><name><surname>Matheus</surname><given-names>DA</given-names></name><name><surname>Pringle</surname><given-names>CR</given-names></name></person-group><article-title>Identification of variable domains of the attachment (G) protein of subgroup A respiratory syncytial virus</article-title><source>J Gen Virol</source><year>1991</year><volume>72</volume><fpage>2091</fpage><lpage>2096</lpage><pub-id pub-id-type="doi">10.1099/0022-1317-72-9-2091</pub-id><?supplied-pmid 1895054?><pub-id pub-id-type="pmid">1895054</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cane</surname><given-names>PA</given-names></name><name><surname>Matthews</surname><given-names>DA</given-names></name><name><surname>Pringle</surname><given-names>CR</given-names></name></person-group><article-title>Analysis of relatedness of subgroup A respiratory syncytial viruses isolated worldwide</article-title><source>Virus Res</source><year>1992</year><volume>25</volume><fpage>15</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1016/0168-1702(92)90096-R</pub-id><?supplied-pmid 1413992?><pub-id pub-id-type="pmid">1413992</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cane</surname><given-names>PA</given-names></name><name><surname>Matthews</surname><given-names>DA</given-names></name><name><surname>Pringle</surname><given-names>CR</given-names></name></person-group><article-title>Analysis of respiratory syncytial virus strain variation in successive epidemics in one city</article-title><source>J Clin Microbiol</source><year>1994</year><volume>32</volume><fpage>1</fpage><lpage>4</lpage><?supplied-pmid 8126162?><pub-id pub-id-type="pmid">8126162</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cane</surname><given-names>PA</given-names></name><name><surname>Pringle</surname><given-names>CR</given-names></name></person-group><article-title>Respiratory syncytial virus heterogeneity during an epidemic: analysis by limited nucleotide sequencing (SH gene) and restriction mapping (N gene)</article-title><source>J Gen Virol</source><year>1991</year><volume>72</volume><fpage>349</fpage><lpage>357</lpage><pub-id pub-id-type="doi">10.1099/0022-1317-72-2-349</pub-id><?supplied-pmid 1993875?><pub-id pub-id-type="pmid">1993875</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cane</surname><given-names>PA</given-names></name><name><surname>Prince</surname><given-names>CR</given-names></name></person-group><article-title>Evolution of subgroup a respiratory syncytial virus: Evidence for progressive accumulation of amino acid changes in the attachment protein</article-title><source>J Virol</source><year>1995</year><volume>69</volume><fpage>2918</fpage><lpage>2925</lpage><?supplied-pmid 7707517?><pub-id pub-id-type="pmid">7707517</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carballal</surname><given-names>G</given-names></name><name><surname>Videla</surname><given-names>CM</given-names></name><name><surname>Espino</surname><given-names>MA</given-names></name><name><surname>Savy</surname><given-names>V</given-names></name><name><surname>Uez</surname><given-names>O</given-names></name><name><surname>Sequeira</surname><given-names>MD</given-names></name><name><surname>Knez</surname><given-names>V</given-names></name><name><surname>Requeijo</surname><given-names>PV</given-names></name><name><surname>Posse</surname><given-names>CR</given-names></name><name><surname>Miceli</surname><given-names>I</given-names></name></person-group><article-title>Multicentered study of viral acute lower respiratory infections in children from four cities of Argentina, 1993&#x02013;1994</article-title><source>J Med Virol</source><year>2001</year><volume>64</volume><fpage>164</fpage><lpage>174</lpage><pub-id pub-id-type="doi">10.1002/jmv.1032</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carballal</surname><given-names>G</given-names></name><name><surname>Videla</surname><given-names>CM</given-names></name><name><surname>Sequeira</surname><given-names>MD</given-names></name><name><surname>Mistchenko</surname><given-names>A</given-names></name><name><surname>Requeijo</surname><given-names>PV</given-names></name><name><surname>Arbiza</surname><given-names>J</given-names></name></person-group><article-title>Respiratory syncytial virus: changes in prevalence of subgroups A and B among Argentinian children, 1990&#x02013;1996</article-title><source>J Med Virol</source><year>2000</year><volume>61</volume><fpage>275</fpage><lpage>279</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1096-9071(200006)61:2&#x0003c;275::AID-JMV15&#x0003e;3.0.CO;2-E</pub-id><?supplied-pmid 10797385?><pub-id pub-id-type="pmid">10797385</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>CDC-Centers for Disease Control and Prevention</collab></person-group><article-title>Respiratory syncytial virus circulation in the United States, July 2012&#x02013;June 2014</article-title><source>MMWR</source><year>2014</year><volume>62</volume><fpage>141</fpage><lpage>144</lpage></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chanock</surname><given-names>RM</given-names></name><name><surname>Roizman</surname><given-names>B</given-names></name><name><surname>Myers</surname><given-names>R</given-names></name></person-group><article-title>Recovery from infants with respiratory illness of virus related to chimpanzee coryza agent. I. isolation, properties and characterization</article-title><source>Am J Hyg</source><year>1957</year><volume>66</volume><fpage>281</fpage><lpage>290</lpage><?supplied-pmid 13478578?><pub-id pub-id-type="pmid">13478578</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chanock</surname><given-names>RM</given-names></name><name><surname>Finberg</surname><given-names>L</given-names></name></person-group><article-title>Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA). II. Epidemiological aspects of infection in infants and young children</article-title><source>Am J Hyg</source><year>1957</year><volume>66</volume><fpage>291</fpage><lpage>300</lpage><?supplied-pmid 13478579?><pub-id pub-id-type="pmid">13478579</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>E</given-names></name><name><surname>Lee</surname><given-names>H</given-names></name></person-group><article-title>Genetic diversity and molecular epidemiology of the G protein of subgroups A and B of respiratory syncytial virus isolated over 9 consecutive epidemics in Korea</article-title><source>J Infect Dis</source><year>2000</year><volume>181</volume><fpage>1547</fpage><lpage>1556</lpage><pub-id pub-id-type="doi">10.1086/315468</pub-id><?supplied-pmid 10823752?><pub-id pub-id-type="pmid">10823752</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christensen</surname><given-names>LS</given-names></name><name><surname>Larsen</surname><given-names>LB</given-names></name><name><surname>Johansen</surname><given-names>J</given-names></name><name><surname>Andersen</surname><given-names>EA</given-names></name><name><surname>Wejse</surname><given-names>C</given-names></name><name><surname>Klug</surname><given-names>B</given-names></name><name><surname>Hornsleth</surname><given-names>A</given-names></name></person-group><article-title>The fluctuating pattern of various genome types of respiratory syncytial virus in copenhagen and some other locations in Denmark</article-title><source>APMIS</source><year>1999</year><volume>107</volume><fpage>843</fpage><lpage>850</lpage><pub-id pub-id-type="doi">10.1111/j.1699-0463.1999.tb01481.x</pub-id><?supplied-pmid 10519320?><pub-id pub-id-type="pmid">10519320</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cintra</surname><given-names>OA</given-names></name><name><surname>Owa</surname><given-names>MA</given-names></name><name><surname>Machado</surname><given-names>AA</given-names></name><name><surname>Cervi</surname><given-names>MC</given-names></name><name><surname>Figueiredo</surname><given-names>LT</given-names></name><name><surname>Rocha</surname><given-names>GM</given-names></name><etal/></person-group><article-title>Occurrence and severity of infections caused by subgroup A and B respiratory syncytial virus in children in southeast Brazil</article-title><source>J Med Virol</source><year>2001</year><volume>65</volume><issue>2</issue><fpage>408</fpage><lpage>412</lpage><pub-id pub-id-type="doi">10.1002/jmv.2049</pub-id><?supplied-pmid 11536252?><pub-id pub-id-type="pmid">11536252</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wb</surname><given-names>C</given-names></name><name><surname>Ej</surname><given-names>L</given-names></name><name><surname>Wm</surname><given-names>S</given-names></name></person-group><article-title>Genetic variability among group A and group B respiratory syncytial virus in a children&#x02019;s hospital</article-title><source>J Clin Microbiol</source><year>1998</year><volume>36</volume><fpage>35552</fpage><lpage>35557</lpage></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname><given-names>PL</given-names></name><name><surname>Dickens</surname><given-names>LE</given-names></name><name><surname>Buckler-White</surname><given-names>A</given-names></name><name><surname>Olmsted</surname><given-names>RA</given-names></name><name><surname>Spriggs</surname><given-names>MK</given-names></name><name><surname>Camargo</surname><given-names>E</given-names></name><etal/></person-group><article-title>Nucleotide sequences for the gene junctions of human respiratory syncytial virus reveal distinctive features of intergenic structure and gene order</article-title><source>Proc Natl Acad Sci U S A</source><year>1986</year><volume>83</volume><issue>13</issue><fpage>4594</fpage><lpage>4598</lpage><pub-id pub-id-type="doi">10.1073/pnas.83.13.4594</pub-id><?supplied-pmid 3460060?><pub-id pub-id-type="pmid">3460060</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname><given-names>PL</given-names></name><name><surname>Hill</surname><given-names>MG</given-names></name><name><surname>Camargo</surname><given-names>E</given-names></name><name><surname>Grosfeld</surname><given-names>H</given-names></name><name><surname>Chanock</surname><given-names>RM</given-names></name><name><surname>Murphy</surname><given-names>BR</given-names></name></person-group><article-title>Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5&#x02032; proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development</article-title><source>Proc Natl Acad Sci U S A</source><year>1995</year><volume>92</volume><issue>25</issue><fpage>11563</fpage><lpage>11567</lpage><pub-id pub-id-type="doi">10.1073/pnas.92.25.11563</pub-id><?supplied-pmid 8524804?><pub-id pub-id-type="pmid">8524804</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><mixed-citation publication-type="other">Collins PL, McIntosh K, Chanock RM (1996) Respiratory syncytial virus. In: Fields BN, Knipe DM, Howley PM (eds) Fields virology, 3rd edn. Lippincott-Raven, Philadelphia, pp 1313&#x02013;1351</mixed-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Collins</surname><given-names>PL</given-names></name><name><surname>Chanock</surname><given-names>RM</given-names></name><name><surname>Murphy</surname><given-names>FBR</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Fields</surname><given-names>BN</given-names></name></person-group><article-title>Respiratory syncytial v&#x000ed;rus</article-title><source>Fields virology</source><year>2001</year><edition>4th</edition><publisher-loc>Philadelphia/New York</publisher-loc><publisher-name>Lippincott-Raven</publisher-name></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costa</surname><given-names>LF</given-names></name><name><surname>Yokosawa</surname><given-names>J</given-names></name><name><surname>Mantese</surname><given-names>OC</given-names></name><name><surname>Oliveira</surname><given-names>TF</given-names></name><name><surname>Silveira</surname><given-names>HL</given-names></name><name><surname>Nepomuceno</surname><given-names>LL</given-names></name><name><surname>Moreira</surname><given-names>LS</given-names></name><name><surname>Dyonisio</surname><given-names>G</given-names></name><name><surname>Rossi</surname><given-names>LM</given-names></name><name><surname>Oliveira</surname><given-names>RC</given-names></name><name><surname>Ribeiro</surname><given-names>LZ</given-names></name><name><surname>Queir&#x000f3;z</surname><given-names>DA</given-names></name></person-group><article-title>Respiratory v&#x000ed;rus in children younger than five years old with acute respiratory disease from 2001 to 2004 in Uberl&#x000e2;ndia, MG, Brazil</article-title><source>Mem Inst Oswaldo Cruz</source><year>2006</year><volume>101</volume><issue>3</issue><fpage>301</fpage><lpage>306</lpage><pub-id pub-id-type="doi">10.1590/S0074-02762006000300014</pub-id><?supplied-pmid 16862327?><pub-id pub-id-type="pmid">16862327</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname><given-names>MJ</given-names></name><name><surname>Azevedo</surname><given-names>RS</given-names></name><name><surname>Cane</surname><given-names>PA</given-names></name><name><surname>Massad</surname><given-names>E</given-names></name><name><surname>Medley</surname><given-names>GF</given-names></name></person-group><article-title>Seroepidemiological study of respiratory syncytial virus in S&#x000e3;o Paulo state, Brazil</article-title><source>Med Virol</source><year>1998</year><volume>55</volume><fpage>234</fpage><lpage>239</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1096-9071(199807)55:3&#x0003c;234::AID-JMV9&#x0003e;3.0.CO;2-2</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crowe</surname><given-names>JE</given-names></name></person-group><article-title>Respiratory syncytial virus vaccine development</article-title><source>Vaccine</source><year>2002</year><volume>20</volume><fpage>S32</fpage><lpage>S37</lpage><pub-id pub-id-type="doi">10.1016/S0264-410X(01)00287-0</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dapat</surname><given-names>IC</given-names></name><name><surname>Shobugawa</surname><given-names>Y</given-names></name><name><surname>Sano</surname><given-names>Y</given-names></name><name><surname>Saito</surname><given-names>R</given-names></name><name><surname>Sasaki</surname><given-names>A</given-names></name><name><surname>Suzuki</surname><given-names>Y</given-names></name><name><surname>Kumaki</surname><given-names>A</given-names></name><name><surname>Zaraket</surname><given-names>H</given-names></name><name><surname>Dapat</surname><given-names>C</given-names></name><name><surname>Oguma</surname><given-names>T</given-names></name><name><surname>Yamaguchi</surname><given-names>M</given-names></name><name><surname>Suzuki</surname><given-names>H</given-names></name></person-group><article-title>New genotypes within respiratory syncytial virus group B, genotype BA in Niigata, Japan</article-title><source>J Clin Microbiol</source><year>2010</year><volume>48</volume><issue>9</issue><fpage>3423</fpage><lpage>3427</lpage><pub-id pub-id-type="doi">10.1128/JCM.00646-10</pub-id><?supplied-pmid 20610675?><pub-id pub-id-type="pmid">20610675</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Debur</surname><given-names>MC</given-names></name><name><surname>Vidal</surname><given-names>LR</given-names></name><name><surname>Stroparo</surname><given-names>E</given-names></name><name><surname>Nogueira</surname><given-names>MB</given-names></name><name><surname>Almeida</surname><given-names>SM</given-names></name><name><surname>Takahashi</surname><given-names>GA</given-names></name><name><surname>Rotta</surname><given-names>I</given-names></name><name><surname>Pereira</surname><given-names>LA</given-names></name><name><surname>Silveira</surname><given-names>CS</given-names></name><name><surname>Delfraro</surname><given-names>A</given-names></name><name><surname>Nakatani</surname><given-names>SM</given-names></name><name><surname>Skraba</surname><given-names>I</given-names></name><name><surname>Raboni</surname><given-names>SM</given-names></name></person-group><article-title>Impact of human metapneumovirus infection on in and outpatients for the years 2006-2008 in Southern Brazil</article-title><source>Mem Inst Oswaldo Cruz</source><year>2010</year><volume>105</volume><issue>8</issue><fpage>1010</fpage><lpage>1018</lpage><pub-id pub-id-type="doi">10.1590/S0074-02762010000800010</pub-id><?supplied-pmid 21225198?><pub-id pub-id-type="pmid">21225198</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durigon</surname><given-names>GS</given-names></name><name><surname>Oliveira</surname><given-names>DB</given-names></name><name><surname>Vollet</surname><given-names>SB</given-names></name><name><surname>Storni</surname><given-names>JG</given-names></name><name><surname>Fel&#x000ed;cio</surname><given-names>MC</given-names></name><name><surname>Finelli</surname><given-names>C</given-names></name><name><surname>Piera</surname><given-names>J</given-names></name><name><surname>Magalh&#x000e3;es</surname><given-names>M</given-names></name><name><surname>Caldeira</surname><given-names>RN</given-names></name><name><surname>Barbosa</surname><given-names>ML</given-names></name><name><surname>Durigon</surname><given-names>EL</given-names></name><name><surname>Berezin</surname><given-names>EN</given-names></name></person-group><article-title>Hospital-acquired human bocavirus in infants</article-title><source>J Hosp Infect</source><year>2010</year><volume>76</volume><issue>2</issue><fpage>171</fpage><lpage>173</lpage><pub-id pub-id-type="doi">10.1016/j.jhin.2010.04.028</pub-id><?supplied-pmid 20619493?><pub-id pub-id-type="pmid">20619493</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durigon</surname><given-names>GS</given-names></name><name><surname>Oliveira</surname><given-names>DB</given-names></name><name><surname>Felicio</surname><given-names>MC</given-names></name><name><surname>Finelli</surname><given-names>C</given-names></name><name><surname>Pereira</surname><given-names>MF</given-names></name><name><surname>Storni</surname><given-names>JG</given-names></name><etal/></person-group><article-title>Poor outcome of acute respiratory infection in young children with underlying health condition in Brazil</article-title><source>Int J Infect Dis</source><year>2015</year><volume>34</volume><fpage>3</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/j.ijid.2015.03.003</pub-id><?supplied-pmid 25747778?><pub-id pub-id-type="pmid">25747778</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><mixed-citation publication-type="other">Colmanetti TC, Oliveira DBL, Botosso VF, Thomazelli LM, Pinez CMN, Crema D, Mesquita FS, Vieira SE, Gilio AE, Martinez MB, Durigon EL (2015) Naturally dominance of RSV, a N276S mutation in protein palivizumab binding site in new genotypes oni-1 and na1-2-3. Presented at Clinical Virological Symposium.2015</mixed-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eshaghi</surname><given-names>A</given-names></name><name><surname>Duvvuri</surname><given-names>VR</given-names></name><name><surname>Lai</surname><given-names>R</given-names></name><name><surname>Nadarajah</surname><given-names>JT</given-names></name><name><surname>Li</surname><given-names>A</given-names></name><name><surname>Patel</surname><given-names>SN</given-names></name><name><surname>Low</surname><given-names>DE</given-names></name><name><surname>Gubbay</surname><given-names>JB</given-names></name></person-group><article-title>Genetic variability of human respiratory syncytial virus A strains circulating in Ontario: a novel genotype with a 72 nucleotide G gene duplication</article-title><source>PLoS One</source><year>2012</year><volume>7</volume><issue>3</issue><fpage>e32807</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0032807</pub-id><?supplied-pmid 22470426?><pub-id pub-id-type="pmid">22470426</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Falsey</surname><given-names>AR</given-names></name></person-group><article-title>Respiratory syncytial virus infection in elderly and high-risk adults</article-title><source>Exp Lung Res</source><year>2005</year><volume>31</volume><issue>1</issue><fpage>77</fpage><?supplied-pmid 16395866?><pub-id pub-id-type="pmid">16395866</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forster</surname><given-names>J</given-names></name><name><surname>Ihorst</surname><given-names>G</given-names></name><name><surname>Rieger</surname><given-names>CH</given-names></name><name><surname>Stephan</surname><given-names>V</given-names></name><name><surname>Frank</surname><given-names>HD</given-names></name><name><surname>Gurth</surname><given-names>H</given-names></name><name><surname>Berner</surname><given-names>R</given-names></name><name><surname>Rohwedder</surname><given-names>A</given-names></name><name><surname>Werchau</surname><given-names>H</given-names></name><name><surname>Schumacher</surname><given-names>M</given-names></name><name><surname>Tsai</surname><given-names>T</given-names></name><name><surname>Petersen</surname><given-names>G</given-names></name></person-group><article-title>Prospective population-based study of viral lower respiratory tract infection in children under 3 years of age</article-title><source>Eur J Pediatr</source><year>2004</year><volume>163</volume><fpage>709</fpage><lpage>716</lpage><pub-id pub-id-type="doi">10.1007/s00431-004-1523-9</pub-id><?supplied-pmid 15372233?><pub-id pub-id-type="pmid">15372233</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fry</surname><given-names>AM</given-names></name><name><surname>Chittaganpitch</surname><given-names>M</given-names></name><name><surname>Baggett</surname><given-names>HC</given-names></name><name><surname>Peret</surname><given-names>TC</given-names></name><name><surname>Dare</surname><given-names>RK</given-names></name><name><surname>Sawatwong</surname><given-names>P</given-names></name><etal/></person-group><article-title>The burden of hospitalized lower respiratory tract infection due to respiratory syncytial virus in rural Thailand</article-title><source>PLoS One</source><year>2010</year><volume>5</volume><issue>11</issue><fpage>e15098</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0015098</pub-id><?supplied-pmid 21152047?><pub-id pub-id-type="pmid">21152047</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gamba-Sanchez</surname><given-names>N</given-names></name><name><surname>Rodriguez-Martinez</surname><given-names>CE</given-names></name><name><surname>Sossa-Briceno</surname><given-names>MP</given-names></name></person-group><article-title>Epidemic activity of respiratory syncytial virus is related to temperature and rainfall in equatorial tropical countries</article-title><source>Epidemiol Infect</source><year>2016</year><volume>144</volume><issue>10</issue><fpage>2057</fpage><lpage>2063</lpage><pub-id pub-id-type="doi">10.1017/S0950268816000273</pub-id><?supplied-pmid 26888544?><pub-id pub-id-type="pmid">26888544</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia</surname><given-names>CG</given-names></name><name><surname>Bhore</surname><given-names>R</given-names></name><name><surname>Soriano-Fallas</surname><given-names>A</given-names></name><name><surname>Trost</surname><given-names>M</given-names></name><name><surname>Chanson</surname><given-names>R</given-names></name><name><surname>Ramilo</surname><given-names>O</given-names></name><name><surname>Mejias</surname><given-names>A</given-names></name></person-group><article-title>A Risk factors in children hospitalized with RSV bronchiolitis versus non-RSV bronchiolitis</article-title><source>Pediatrics</source><year>2010</year><volume>126</volume><issue>6</issue><fpage>e1453</fpage><lpage>e1460</lpage><pub-id pub-id-type="doi">10.1542/peds.2010-0507</pub-id><?supplied-pmid 21098154?><pub-id pub-id-type="pmid">21098154</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia</surname><given-names>MLG</given-names></name><name><surname>Gabin</surname><given-names>MO</given-names></name><name><surname>Rey</surname><given-names>CC</given-names></name><name><surname>Alvarez</surname><given-names>MIG</given-names></name><name><surname>Ruiz</surname><given-names>JA</given-names></name><name><surname>Sierra</surname><given-names>AA</given-names></name><name><surname>Bre&#x000f1;a</surname><given-names>PP</given-names></name></person-group><article-title>Infecciones virales de vias respirat&#x000f3;rias inferiors en lactentes hospitalizados: etiolog&#x000ed;a, caracter&#x000ed;sticas cl&#x000ed;nicas y factores de riesgo</article-title><source>An Esp Pediatr</source><year>2001</year><volume>55</volume><fpage>101</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.1016/S1695-4033(01)77644-8</pub-id><pub-id pub-id-type="pmid">11472660</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia</surname><given-names>O</given-names></name><name><surname>Martin</surname><given-names>M</given-names></name><name><surname>Dopazo</surname><given-names>J</given-names></name><name><surname>Arbiza</surname><given-names>J</given-names></name><name><surname>Frabasile</surname><given-names>S</given-names></name><name><surname>Russsi</surname><given-names>J</given-names></name><name><surname>Hortal</surname><given-names>M</given-names></name><name><surname>Perez-Brena</surname><given-names>P</given-names></name><name><surname>Martinez</surname><given-names>I</given-names></name><name><surname>Garcia-Barreno</surname><given-names>B</given-names></name><name><surname>Melero</surname><given-names>JA</given-names></name></person-group><article-title>Evolutionary pattern of human respiratory syncytial virus (subgroup A): cocirculating lineages and correlation of genetic and antigenic changes in the G glicoprotein</article-title><source>J Virol</source><year>1994</year><volume>68</volume><fpage>5448</fpage><lpage>5459</lpage><?supplied-pmid 8057427?><pub-id pub-id-type="pmid">8057427</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilbert</surname><given-names>LL</given-names></name><name><surname>Dakhama</surname><given-names>A</given-names></name><name><surname>Bone</surname><given-names>BM</given-names></name><name><surname>Thomas</surname><given-names>EE</given-names></name><name><surname>Hegele</surname><given-names>RG</given-names></name></person-group><article-title>Diagnosis of viral respiratory tract infections in children by using a reverse transcription-PCR panel</article-title><source>J Clin Microbiol</source><year>1996</year><volume>34</volume><fpage>140</fpage><lpage>143</lpage><?supplied-pmid 8748290?><pub-id pub-id-type="pmid">8748290</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gimenez</surname><given-names>HB</given-names></name><name><surname>Hardman</surname><given-names>N</given-names></name><name><surname>Keir</surname><given-names>HM</given-names></name><name><surname>Cash</surname><given-names>P</given-names></name></person-group><article-title>Antigenic variation between human respiratory syncytial virus isolates</article-title><source>J Gen Virol</source><year>1986</year><volume>67</volume><issue>pt 5</issue><fpage>863</fpage><lpage>870</lpage><pub-id pub-id-type="doi">10.1099/0022-1317-67-5-863</pub-id><?supplied-pmid 3517224?><pub-id pub-id-type="pmid">3517224</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gottschalk</surname><given-names>J</given-names></name><name><surname>Zbinden</surname><given-names>R</given-names></name><name><surname>Kaempf</surname><given-names>L</given-names></name><name><surname>Heinzer</surname><given-names>I</given-names></name></person-group><article-title>Discrimination of respiratory syncytial virus subgroups A and B by reverse transcription-PCR</article-title><source>J Clin Microbiol</source><year>1996</year><volume>34</volume><fpage>41</fpage><lpage>43</lpage><?supplied-pmid 8748269?><pub-id pub-id-type="pmid">8748269</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname><given-names>CB</given-names></name><name><surname>Keith</surname><given-names>RP</given-names></name><name><surname>Macdonald</surname><given-names>NE</given-names></name><name><surname>Gala</surname><given-names>CL</given-names></name><name><surname>Menegus</surname><given-names>ME</given-names></name><name><surname>Suffin</surname><given-names>SC</given-names></name><name><surname>Cohen</surname><given-names>HJ</given-names></name></person-group><article-title>Respiratory syncytial viral infection in children with compromised immune function</article-title><source>N Engl J Med</source><year>1986</year><volume>315</volume><fpage>77</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1056/NEJM198607103150201</pub-id><?supplied-pmid 3724802?><pub-id pub-id-type="pmid">3724802</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname><given-names>CB</given-names></name><name><surname>Walsh</surname><given-names>EE</given-names></name><name><surname>Long</surname><given-names>CE</given-names></name><name><surname>Schnabel</surname><given-names>KC</given-names></name></person-group><article-title>Immunity to and frequency of reinfection with respiratory syncytial virus</article-title><source>J Infect Dis</source><year>1991</year><volume>163</volume><fpage>693</fpage><lpage>698</lpage><pub-id pub-id-type="doi">10.1093/infdis/163.4.693</pub-id><?supplied-pmid 2010624?><pub-id pub-id-type="pmid">2010624</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname><given-names>CB</given-names></name><name><surname>Walsh</surname><given-names>EE</given-names></name><name><surname>Schnabel</surname><given-names>KC</given-names></name><name><surname>Long</surname><given-names>CE</given-names></name><name><surname>Mcconnochie</surname><given-names>KM</given-names></name><name><surname>Hildreth</surname><given-names>SW</given-names></name><name><surname>Anderson</surname><given-names>LJ</given-names></name></person-group><article-title>Occurrence of groups A and B of respiratory syncytial virus over 15 years: associated epidemiologic and clinical characteristics in hospitalized and ambulatory children</article-title><source>J Infect Dis</source><year>1990</year><volume>162</volume><fpage>1283</fpage><lpage>1290</lpage><pub-id pub-id-type="doi">10.1093/infdis/162.6.1283</pub-id><?supplied-pmid 2230258?><pub-id pub-id-type="pmid">2230258</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harrington</surname><given-names>RD</given-names></name><name><surname>Hackman</surname><given-names>EC</given-names></name><name><surname>Storch</surname><given-names>GA</given-names></name><name><surname>Osborne</surname><given-names>B</given-names></name><name><surname>Gleaves</surname><given-names>CA</given-names></name><name><surname>Benson</surname><given-names>A</given-names></name><name><surname>Meyers</surname><given-names>JD</given-names></name></person-group><article-title>An outbreak of respiratory syncytial virus in a bone marrow transplant center</article-title><source>J Infect Dis</source><year>1992</year><volume>153</volume><fpage>291</fpage><lpage>297</lpage></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hendry</surname><given-names>RM</given-names></name><name><surname>Pierik</surname><given-names>LT</given-names></name><name><surname>Mcintosh</surname><given-names>K</given-names></name></person-group><article-title>Prevalence of respiratory syncytial virus subgroups over six consecutive outbreaks: 1981&#x02013;1987</article-title><source>J Infect Dis.</source><year>1989</year><volume>160</volume><fpage>185</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.1093/infdis/160.2.185</pub-id><?supplied-pmid 2760479?><pub-id pub-id-type="pmid">2760479</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henkel</surname><given-names>JH</given-names></name><name><surname>Aberle</surname><given-names>SW</given-names></name><name><surname>Kundi</surname><given-names>M</given-names></name><name><surname>Popow-Kraupp</surname><given-names>T</given-names></name></person-group><article-title>Improved detection of respiratory syncytial virus in nasal aspirates by seminested RT-PCR</article-title><source>J Med Virol</source><year>1997</year><volume>53</volume><fpage>366</fpage><lpage>371</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1096-9071(199712)53:4&#x0003c;366::AID-JMV9&#x0003e;3.0.CO;2-5</pub-id><?supplied-pmid 9407385?><pub-id pub-id-type="pmid">9407385</pub-id></element-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hierholzer</surname><given-names>JC</given-names></name><name><surname>Tannock</surname><given-names>GA</given-names></name><name><surname>Hierholzer</surname><given-names>CM</given-names></name><name><surname>Coombs</surname><given-names>RA</given-names></name><name><surname>Kennett</surname><given-names>ML</given-names></name><name><surname>Phillips</surname><given-names>PA</given-names></name><name><surname>Gust</surname><given-names>ID</given-names></name></person-group><article-title>Subgrouping of respiratory syncytial virus strains from Australia and Papua New Guinea by biological and antigenic characteristics</article-title><source>Arch Virol</source><year>1994</year><volume>136</volume><fpage>133</fpage><lpage>147</lpage><pub-id pub-id-type="doi">10.1007/BF01538823</pub-id><?supplied-pmid 8002781?><pub-id pub-id-type="pmid">8002781</pub-id></element-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hortal</surname><given-names>M</given-names></name><name><surname>Suarez</surname><given-names>A</given-names></name><name><surname>Deleon</surname><given-names>C</given-names></name><name><surname>Estevan</surname><given-names>M</given-names></name><name><surname>Mogdasy</surname><given-names>MC</given-names></name><name><surname>Russi</surname><given-names>JC</given-names></name><name><surname>Contera</surname><given-names>M</given-names></name><name><surname>Meny</surname><given-names>M</given-names></name></person-group><article-title>Etiology and severity of community acquired pneumonia in children from Uruguay: a 4-year study</article-title><source>Rev Inst Med Trop S&#x000e3;o Paulo</source><year>1994</year><volume>36</volume><fpage>255</fpage><lpage>264</lpage><pub-id pub-id-type="doi">10.1590/S0036-46651994000300010</pub-id><?supplied-pmid 7855490?><pub-id pub-id-type="pmid">7855490</pub-id></element-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hughes</surname><given-names>JH</given-names></name><name><surname>Mann</surname><given-names>DR</given-names></name><name><surname>Hamparian</surname><given-names>VV</given-names></name></person-group><article-title>Detection of virus respiratory syncytial virus in clinical specimens by viral culture, direct and indirect immunofluorescence, and enzyme immunoassay</article-title><source>J Clin Microbiol</source><year>1988</year><volume>26</volume><fpage>588</fpage><lpage>591</lpage><?supplied-pmid 3281981?><pub-id pub-id-type="pmid">3281981</pub-id></element-citation></ref><ref id="CR63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imaz</surname><given-names>MS</given-names></name><name><surname>Sequeira</surname><given-names>MD</given-names></name><name><surname>Videla</surname><given-names>C</given-names></name><name><surname>Veronessi</surname><given-names>I</given-names></name><name><surname>Cociglio</surname><given-names>R</given-names></name><name><surname>Zerbini</surname><given-names>E</given-names></name><name><surname>Carballal</surname><given-names>G</given-names></name></person-group><article-title>Clinical and epidemiological characteristics of respiratory syncytial virus subgroups A and B infections in Santa Fe, Argentina</article-title><source>J Med Virol</source><year>2000</year><volume>61</volume><fpage>76</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1096-9071(200005)61:1&#x0003c;76::AID-JMV12&#x0003e;3.0.CO;2-P</pub-id><?supplied-pmid 10745236?><pub-id pub-id-type="pmid">10745236</pub-id></element-citation></ref><ref id="CR64"><label>64.</label><mixed-citation publication-type="other">Iwane MK, et al., New Vaccine Surveillance Network (2004) Population-based surveillance for hospitalizations associated with respiratory syncytial v&#x000ed;rus, influenza v&#x000ed;rus e parainfluenza v&#x000ed;ruses among young children. Pediatrics 113:1758&#x02013;1764</mixed-citation></ref><ref id="CR65"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johansen</surname><given-names>J</given-names></name><name><surname>Christensens</surname><given-names>LS</given-names></name><name><surname>Hornsleth</surname><given-names>A</given-names></name><name><surname>Klug</surname><given-names>B</given-names></name><name><surname>Hansn</surname><given-names>KS</given-names></name><name><surname>Nir</surname><given-names>M</given-names></name></person-group><article-title>Restriction pattern variability of respiratory syncytial virus during three consecutive epidemics in Denmark</article-title><source>APMIS</source><year>1997</year><volume>105</volume><fpage>303</fpage><lpage>308</lpage><pub-id pub-id-type="doi">10.1111/j.1699-0463.1997.tb00573.x</pub-id><?supplied-pmid 9164473?><pub-id pub-id-type="pmid">9164473</pub-id></element-citation></ref><ref id="CR66"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>PR</given-names><suffix>Jr</suffix></name><name><surname>Olmsted</surname><given-names>RA</given-names></name><name><surname>Prince</surname><given-names>GA</given-names></name><name><surname>Murphy</surname><given-names>BR</given-names></name><name><surname>Alling</surname><given-names>DW</given-names></name><name><surname>Walsh</surname><given-names>EE</given-names></name><name><surname>Collins</surname><given-names>PL</given-names></name></person-group><article-title>Antigenic relatedness between glycoproteins of human respiratory syncytial virus subgroups A and B: evaluation of the contributions of F and G glycoproteins to immunity</article-title><source>J Virol</source><year>1987</year><volume>61</volume><fpage>3163</fpage><lpage>3166</lpage><?supplied-pmid 3305988?><pub-id pub-id-type="pmid">3305988</pub-id></element-citation></ref><ref id="CR67"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>PR</given-names></name><name><surname>Spriggs</surname><given-names>MK</given-names></name><name><surname>Olmsted</surname><given-names>RA</given-names></name><name><surname>Collins</surname><given-names>PL</given-names></name></person-group><article-title>The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteins</article-title><source>Proc Natl Acad Sci U S A</source><year>1987</year><volume>84</volume><issue>16</issue><fpage>5625</fpage><lpage>5629</lpage><pub-id pub-id-type="doi">10.1073/pnas.84.16.5625</pub-id><?supplied-pmid 2441388?><pub-id pub-id-type="pmid">2441388</pub-id></element-citation></ref><ref id="CR68"><label>68.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Kfouri</surname><given-names>RA</given-names></name><name><surname>Wagner</surname><given-names>NH</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Neto</surname><given-names>VA</given-names></name></person-group><article-title>Infec&#x000e7;&#x000e3;o pelo virus Sincicial Respirat&#x000f3;rio</article-title><source>Imuniza&#x000e7;&#x000f5;es: atualiza&#x000e7;&#x000f5;es, orienta&#x000e7;&#x000f5;es e segest&#x000f5;es</source><year>2011</year><publisher-loc>S&#x000e3;o Paulo</publisher-loc><publisher-name>Segmento Farma</publisher-name></element-citation></ref><ref id="CR69"><label>69.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Kingsbury</surname><given-names>DW</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Fields</surname><given-names>BN</given-names></name></person-group><article-title>Paramyxoviridae and their replication</article-title><source>Fields virology</source><year>1990</year><publisher-loc>Philadelphia</publisher-loc><publisher-name>Lippincott-Raven</publisher-name><fpage>945</fpage><lpage>962</lpage></element-citation></ref><ref id="CR70"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krusat</surname><given-names>T</given-names></name><name><surname>Streckert</surname><given-names>HJ</given-names></name></person-group><article-title>Heparin-dependent attachment of respiratory syncytial virus (RSV) to host cells</article-title><source>Arch Virol</source><year>1997</year><volume>142</volume><issue>6</issue><fpage>1247</fpage><lpage>1254</lpage><pub-id pub-id-type="doi">10.1007/s007050050156</pub-id><?supplied-pmid 9229012?><pub-id pub-id-type="pmid">9229012</pub-id></element-citation></ref><ref id="CR71"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuo</surname><given-names>L</given-names></name><name><surname>Fearns</surname><given-names>R</given-names></name><name><surname>Collins</surname><given-names>PL</given-names></name></person-group><article-title>The structurally diverse intergenic regions of respiratory syncytial virus do not modulate sequential transcription by a dicistronic minigenome</article-title><source>J Virol</source><year>1996</year><volume>70</volume><issue>9</issue><fpage>6143</fpage><lpage>6150</lpage><?supplied-pmid 8709239?><pub-id pub-id-type="pmid">8709239</pub-id></element-citation></ref><ref id="CR72"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levine</surname><given-names>SR</given-names></name><name><surname>Klaiber-Franco</surname><given-names>R</given-names></name><name><surname>Paradiso</surname><given-names>PR</given-names></name></person-group><article-title>Demonstration that glycoprotein G is the attachment protein of respiratory syncytial virus</article-title><source>J Gen Virol</source><year>1987</year><volume>68</volume><fpage>2521</fpage><lpage>2524</lpage><pub-id pub-id-type="doi">10.1099/0022-1317-68-9-2521</pub-id><?supplied-pmid 3655746?><pub-id pub-id-type="pmid">3655746</pub-id></element-citation></ref><ref id="CR73"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lichtenstein</surname><given-names>DL</given-names></name><name><surname>Roberts</surname><given-names>SR</given-names></name><name><surname>Wertz</surname><given-names>GW</given-names></name><name><surname>Ball</surname><given-names>LA</given-names></name></person-group><article-title>Definition and functional analysis of the signal/anchor domain of the human respiratory syncytial virus glycoprotein</article-title><source>J Gen Virol</source><year>1996</year><volume>77</volume><issue>pt 1</issue><fpage>109</fpage><lpage>118</lpage><pub-id pub-id-type="doi">10.1099/0022-1317-77-1-109</pub-id><?supplied-pmid 8558117?><pub-id pub-id-type="pmid">8558117</pub-id></element-citation></ref><ref id="CR74"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luchsinger</surname><given-names>V</given-names></name><name><surname>Ampuero</surname><given-names>S</given-names></name><name><surname>Palomino</surname><given-names>MA</given-names></name><name><surname>Chnaiderman</surname><given-names>J</given-names></name><name><surname>Levican</surname><given-names>J</given-names></name><name><surname>Gaggero</surname><given-names>A</given-names></name><name><surname>Larra&#x000f1;aga</surname><given-names>CE</given-names></name></person-group><article-title>Comparison of virological profiles of respiratory syncytial virus and rhinovirus in acute lower tract respiratory infections in very young Chilean infants, according to their clinical outcome</article-title><source>J Clin Virol</source><year>2014</year><volume>61</volume><issue>1</issue><fpage>138</fpage><lpage>144</lpage><pub-id pub-id-type="doi">10.1016/j.jcv.2014.06.004</pub-id><?supplied-pmid 24994006?><pub-id pub-id-type="pmid">24994006</pub-id></element-citation></ref><ref id="CR75"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lukic-Grlic</surname><given-names>A</given-names></name><name><surname>Cane</surname><given-names>PA</given-names></name><name><surname>Bace</surname><given-names>A</given-names></name><name><surname>Pringle</surname><given-names>CR</given-names></name><name><surname>Mlinaric-Galinovic</surname><given-names>G</given-names></name><name><surname>Popow-Kraupp</surname><given-names>T</given-names></name></person-group><article-title>Antigenic and genomic diversity of central European respiratory syncytial virus strains</article-title><source>Arch Virol</source><year>1998</year><volume>143</volume><issue>7</issue><fpage>1441</fpage><lpage>1447</lpage><pub-id pub-id-type="doi">10.1007/s007050050388</pub-id><?supplied-pmid 9722887?><pub-id pub-id-type="pmid">9722887</pub-id></element-citation></ref><ref id="CR76"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mackie</surname><given-names>PLK</given-names></name><name><surname>Madge</surname><given-names>PJ</given-names></name><name><surname>Getty</surname><given-names>S</given-names></name><name><surname>Paton</surname><given-names>JY</given-names></name></person-group><article-title>Rapid diagnosis of respiratory syncytial virus by using pernasal swabs</article-title><source>J Clin Microbiol</source><year>1991</year><volume>29</volume><fpage>2653</fpage><lpage>2655</lpage><?supplied-pmid 1774282?><pub-id pub-id-type="pmid">1774282</pub-id></element-citation></ref><ref id="CR77"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinez</surname><given-names>I</given-names></name><name><surname>Valdes</surname><given-names>O</given-names></name><name><surname>Delfraro</surname><given-names>A</given-names></name><name><surname>Arbiza</surname><given-names>J</given-names></name><name><surname>Russi</surname><given-names>J</given-names></name><name><surname>Melero</surname><given-names>JA</given-names></name></person-group><article-title>Evolutionary pattern of the G glycoprotein of human respiratory syncytial virus from antigenic group B: the use of alternative codons and lineage diversification</article-title><source>J Gen Virol</source><year>1999</year><volume>80</volume><fpage>125</fpage><lpage>130</lpage><pub-id pub-id-type="doi">10.1099/0022-1317-80-1-125</pub-id><?supplied-pmid 9934694?><pub-id pub-id-type="pmid">9934694</pub-id></element-citation></ref><ref id="CR78"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Massin</surname><given-names>MM</given-names></name><name><surname>Montesanti</surname><given-names>J</given-names></name><name><surname>Gerard</surname><given-names>P</given-names></name><name><surname>Lepage</surname></name></person-group><article-title>Spectrum and frequency of illness presenting to a pediatric emergency department</article-title><source>Acta Clin Belg</source><year>2006</year><volume>61</volume><fpage>161</fpage><lpage>165</lpage><pub-id pub-id-type="doi">10.1179/acb.2006.027</pub-id><?supplied-pmid 17091911?><pub-id pub-id-type="pmid">17091911</pub-id></element-citation></ref><ref id="CR79"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masters</surname><given-names>HB</given-names></name><name><surname>Weber</surname><given-names>KO</given-names></name><name><surname>Groothuis</surname><given-names>JR</given-names></name><name><surname>Wren</surname><given-names>CG</given-names></name><name><surname>Lauer</surname><given-names>BA</given-names></name></person-group><article-title>Comparison of nasopharyngeal washing and swab specimens for diagnosis of respiratory syncytial virus by EIA, FAT, and cell culture</article-title><source>Diagn Microbiol Infect Dis</source><year>1987</year><volume>8</volume><fpage>101</fpage><lpage>105</lpage><pub-id pub-id-type="doi">10.1016/0732-8893(87)90156-8</pub-id><?supplied-pmid 3322655?><pub-id pub-id-type="pmid">3322655</pub-id></element-citation></ref><ref id="CR80"><label>80.</label><mixed-citation publication-type="other">Mesquita FS, Oliveira DBL, Crema D, Botosso VF, Pinez CMN, Colmanetti TC, Thomazelli, LM, Gilio AE, Martinez MB, Durigon EL (2017) Rapid antigen detection test for respiratory syncytial virus (RSV) diagnosis as a diagnostic tool for use in pediatrics. J Pediatr (Rio J). 2016 Nov 25. pii: S0021-7557(16)30287-X. doi: 10.1016/j.jped.2016.06.013. [Epub ahead of print]</mixed-citation></ref><ref id="CR81"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mink</surname><given-names>MA</given-names></name><name><surname>Stec</surname><given-names>DS</given-names></name><name><surname>Collins</surname><given-names>PL</given-names></name></person-group><article-title>Nucleotide sequences of the 3&#x02032; leader and 5&#x02032; trailer regions of human respiratory syncytial virus genomic RNA</article-title><source>Virology</source><year>1991</year><volume>186</volume><fpage>615</fpage><lpage>624</lpage><pub-id pub-id-type="doi">10.1016/0042-6822(91)90532-G</pub-id></element-citation></ref><ref id="CR82"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morris</surname><given-names>JA</given-names><suffix>Jr</suffix></name><name><surname>Blount</surname><given-names>RE</given-names></name><name><surname>Savage</surname><given-names>RE</given-names></name></person-group><article-title>Recovery of cytopathogenic agent from chimpanzees with coryza</article-title><source>Proc Soc Exp Med</source><year>1956</year><volume>92</volume><fpage>544</fpage><lpage>550</lpage><pub-id pub-id-type="doi">10.3181/00379727-92-22538</pub-id></element-citation></ref><ref id="CR83"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mufson</surname><given-names>MA</given-names></name><name><surname>Belshe</surname><given-names>RB</given-names></name><name><surname>&#x000d6;rvell</surname><given-names>C</given-names></name><name><surname>Norrby</surname><given-names>E</given-names></name></person-group><article-title>Subgroups characteristics of respiratory syncytial virus strains recovered from children with two consecutive infections</article-title><source>J Clin Microbiol</source><year>1987</year><volume>25</volume><fpage>1535</fpage><lpage>1539</lpage><?supplied-pmid 3305568?><pub-id pub-id-type="pmid">3305568</pub-id></element-citation></ref><ref id="CR84"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicholson</surname><given-names>KG</given-names></name><name><surname>McNally</surname><given-names>T</given-names></name><name><surname>Silverman</surname><given-names>M</given-names></name><name><surname>Simons</surname><given-names>P</given-names></name><name><surname>Stockton</surname><given-names>JD</given-names></name><name><surname>Zambon</surname><given-names>MC</given-names></name></person-group><article-title>Rates of hospitalisation for influenza, respiratory syncytial v&#x000ed;rus and human metapneumov&#x000ed;rus among infants and young children</article-title><source>Vaccine</source><year>2006</year><volume>24</volume><fpage>102</fpage><lpage>108</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2005.02.004</pub-id><?supplied-pmid 16310899?><pub-id pub-id-type="pmid">16310899</pub-id></element-citation></ref><ref id="CR85"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oliveira</surname><given-names>DBL</given-names></name><name><surname>Durigon</surname><given-names>EL</given-names></name><name><surname>Carvalho</surname><given-names>ACL</given-names></name><name><surname>Leal</surname><given-names>AL</given-names></name><name><surname>Souza</surname><given-names>TS</given-names></name><name><surname>Thomazelli</surname><given-names>LM</given-names></name><name><surname>Moraes</surname><given-names>CTP</given-names></name><name><surname>Vieira</surname><given-names>SE</given-names></name><name><surname>Al</surname><given-names>G</given-names></name><name><surname>Stewien</surname><given-names>KE</given-names></name></person-group><article-title>Epidemiology and genetic variability of human metapneumov&#x000ed;rus during a 4-year-long study in Southeastern Brazil</article-title><source>J Med Virol</source><year>2009</year><volume>81</volume><fpage>915</fpage><lpage>921</lpage><pub-id pub-id-type="doi">10.1002/jmv.21436</pub-id><?supplied-pmid 19319957?><pub-id pub-id-type="pmid">19319957</pub-id></element-citation></ref><ref id="CR86"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oliveira</surname><given-names>DBL</given-names></name><name><surname>Iwane</surname><given-names>MK</given-names></name><name><surname>Prill</surname><given-names>MM</given-names></name><name><surname>Weinberg</surname><given-names>GA</given-names></name><name><surname>Williams</surname><given-names>JV</given-names></name><name><surname>Griffind</surname><given-names>MR</given-names></name><name><surname>Szilagyi</surname><given-names>PG</given-names></name><name><surname>Edwards</surname><given-names>KM</given-names></name><name><surname>Staat</surname><given-names>MA</given-names></name><name><surname>Hall</surname><given-names>CB</given-names></name><name><surname>Durigon</surname><given-names>EL</given-names></name><name><surname>Erdman</surname><given-names>DD</given-names></name></person-group><article-title>Molecular characterization of respiratory syncytial viruses infecting children reported to have received palivizumab immunoprophylaxis</article-title><source>J Clin Virol</source><year>2015</year><volume>65</volume><fpage>26</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1016/j.jcv.2015.01.016</pub-id><?supplied-pmid 25766983?><pub-id pub-id-type="pmid">25766983</pub-id></element-citation></ref><ref id="CR87"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olszewska</surname><given-names>W</given-names></name><name><surname>Zambon</surname><given-names>M</given-names></name><name><surname>Openshaw</surname><given-names>PJM</given-names></name></person-group><article-title>Development of vaccines against common colds</article-title><source>Br Med Bull</source><year>2002</year><volume>62</volume><fpage>99</fpage><lpage>111</lpage><pub-id pub-id-type="doi">10.1093/bmb/62.1.99</pub-id><?supplied-pmid 12176853?><pub-id pub-id-type="pmid">12176853</pub-id></element-citation></ref><ref id="CR88"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papenburg</surname><given-names>J</given-names></name><name><surname>Carbonneau</surname><given-names>J</given-names></name><name><surname>Hamelin</surname><given-names>ME</given-names></name><name><surname>Isabel</surname><given-names>S</given-names></name><name><surname>Bouhy</surname><given-names>X</given-names></name><name><surname>Ohoumanne</surname><given-names>N</given-names></name><name><surname>D&#x000e9;ry</surname><given-names>P</given-names></name><name><surname>Paes</surname><given-names>BA</given-names></name><name><surname>Corbeil</surname><given-names>J</given-names></name><name><surname>Bergeron</surname><given-names>MG</given-names></name><name><surname>De Serres</surname><given-names>G</given-names></name><name><surname>Boivin</surname><given-names>G</given-names></name></person-group><article-title>Molecular evolution of respiratory syncytial virus fusion gene Canada, 2006&#x02013;2010</article-title><source>Emerg Infect Dis</source><year>2012</year><volume>18</volume><fpage>120</fpage><lpage>124</lpage><pub-id pub-id-type="doi">10.3201/eid1801.110515</pub-id><?supplied-pmid 22264682?><pub-id pub-id-type="pmid">22264682</pub-id></element-citation></ref><ref id="CR89"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pavia</surname><given-names>AT</given-names></name></person-group><article-title>Viral infections of the lower respiratory tract: old viruses, new viruses, and the role of diagnosis</article-title><source>Clin Infect Dis</source><year>2011</year><volume>52</volume><issue>suppl 4</issue><fpage>S284</fpage><lpage>S289</lpage><pub-id pub-id-type="doi">10.1093/cid/cir043</pub-id><?supplied-pmid 21460286?><pub-id pub-id-type="pmid">21460286</pub-id></element-citation></ref><ref id="CR90"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pecchini</surname><given-names>R</given-names></name><name><surname>Rog&#x000e9;rio</surname><given-names>P</given-names></name><name><surname>Berezin</surname><given-names>EN</given-names></name><name><surname>Calahani Fel&#x000ed;cio</surname><given-names>MC</given-names></name><name><surname>Passos</surname><given-names>SD</given-names></name><name><surname>de Souza</surname><given-names>MCO</given-names></name><etal/></person-group><article-title>Incidence and clinical characteristics of the infection by the respiratory syncytial virus in children admitted in Santa Casa de S&#x000e3;o Paulo Hospital</article-title><source>Braz J Infect Dis</source><year>2008</year><volume>12</volume><issue>6</issue><fpage>476</fpage><lpage>479</lpage><pub-id pub-id-type="doi">10.1590/S1413-86702008000600006</pub-id><?supplied-pmid 19287833?><pub-id pub-id-type="pmid">19287833</pub-id></element-citation></ref><ref id="CR91"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>D</given-names></name><name><surname>Zhao</surname><given-names>D</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>K</given-names></name><name><surname>Xicheng</surname><given-names>H</given-names></name><etal/></person-group><article-title>Multipathogen infections in hospitalized children with acute respiratory infections</article-title><source>Virol J</source><year>2009</year><volume>6</volume><issue>1</issue><fpage>155</fpage><lpage>161</lpage><pub-id pub-id-type="doi">10.1186/1743-422X-6-155</pub-id><?supplied-pmid 19788746?><pub-id pub-id-type="pmid">19788746</pub-id></element-citation></ref><ref id="CR92"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peret</surname><given-names>TC</given-names></name><name><surname>Hall</surname><given-names>CB</given-names></name><name><surname>Hammond</surname><given-names>GW</given-names></name><name><surname>Piedra</surname><given-names>PA</given-names></name><name><surname>Storch</surname><given-names>GA</given-names></name><name><surname>Sullender</surname><given-names>WM</given-names></name><etal/></person-group><article-title>Circulation patterns of group A and B human respiratory syncytial virus genotypes in 5 communities in North America</article-title><source>J Infect Dis.</source><year>2000</year><volume>181</volume><issue>6</issue><fpage>1891</fpage><lpage>1896</lpage><pub-id pub-id-type="doi">10.1086/315508</pub-id><?supplied-pmid 10837167?><pub-id pub-id-type="pmid">10837167</pub-id></element-citation></ref><ref id="CR93"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peret</surname><given-names>TC</given-names></name><name><surname>Hall</surname><given-names>CB</given-names></name><name><surname>Schnabel</surname><given-names>KC</given-names></name><name><surname>Golub</surname><given-names>JA</given-names></name><name><surname>Anderson</surname><given-names>LJ</given-names></name></person-group><article-title>Circulation patterns of genetically distinct group A and B strains of human respiratory syncytial virus in a community</article-title><source>J Gen Virol</source><year>1998</year><volume>79</volume><fpage>2221</fpage><lpage>2229</lpage><pub-id pub-id-type="doi">10.1099/0022-1317-79-9-2221</pub-id><?supplied-pmid 9747732?><pub-id pub-id-type="pmid">9747732</pub-id></element-citation></ref><ref id="CR94"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pohl</surname><given-names>C</given-names></name><name><surname>Green</surname><given-names>M</given-names></name><name><surname>Wald</surname><given-names>ER</given-names></name><name><surname>Ledesma-Medina</surname><given-names>J</given-names></name></person-group><article-title>Respiratory syncytial virus infections in pediatric liver transplant recipients</article-title><source>J Infect Dis</source><year>1992</year><volume>165</volume><fpage>166</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.1093/infdis/165.1.166</pub-id><?supplied-pmid 1727886?><pub-id pub-id-type="pmid">1727886</pub-id></element-citation></ref><ref id="CR95"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pontoriero</surname><given-names>AV</given-names></name><name><surname>Baumeister</surname><given-names>EG</given-names></name><name><surname>Campos</surname><given-names>AM</given-names></name><name><surname>Savy</surname><given-names>VL</given-names></name><name><surname>Lin</surname><given-names>YP</given-names></name><name><surname>Hay</surname><given-names>A</given-names></name></person-group><article-title>Antigenic and genomic relation between human influenza v&#x000ed;ruses that circulated in Argentina in the period 1995&#x02013;1999 and the corresponding vaccine components</article-title><source>J Clin Virol</source><year>2003</year><volume>28</volume><issue>2</issue><fpage>130</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1016/S1386-6532(02)00274-3</pub-id><?supplied-pmid 12957183?><pub-id pub-id-type="pmid">12957183</pub-id></element-citation></ref><ref id="CR96"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>JL</given-names></name><name><surname>Lee</surname><given-names>BE</given-names></name><name><surname>Bastien</surname><given-names>N</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name></person-group><article-title>Seasonality and clinical features of human metapneumov&#x000ed;rus infection in children in northern Alberta</article-title><source>J Med Virol</source><year>2005</year><volume>76</volume><fpage>98</fpage><lpage>105</lpage><pub-id pub-id-type="doi">10.1002/jmv.20329</pub-id><?supplied-pmid 15778961?><pub-id pub-id-type="pmid">15778961</pub-id></element-citation></ref><ref id="CR97"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanz</surname><given-names>MC</given-names></name><name><surname>Kew</surname><given-names>OM</given-names></name><name><surname>Anderson</surname><given-names>LJ</given-names></name></person-group><article-title>Genetic heterogeneity of the attachment glycoprotein G among group A respiratory syncytial viruses</article-title><source>Virus Res</source><year>1994</year><volume>33</volume><issue>3</issue><fpage>203</fpage><lpage>217</lpage><pub-id pub-id-type="doi">10.1016/0168-1702(94)90103-1</pub-id><?supplied-pmid 7985408?><pub-id pub-id-type="pmid">7985408</pub-id></element-citation></ref><ref id="CR98"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sauro</surname><given-names>A</given-names></name><name><surname>Barone</surname><given-names>F</given-names></name><name><surname>Blasio</surname><given-names>G</given-names></name><name><surname>Russo</surname><given-names>L</given-names></name><name><surname>Santillo</surname><given-names>L</given-names></name></person-group><article-title>Do influenza and acute respiratory infective diseases weigh heavily on general practitioners&#x02019; daily practice?</article-title><source>Eur J Gen Pract</source><year>2006</year><volume>12</volume><fpage>34</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1080/13814780600757153</pub-id><?supplied-pmid 16945870?><pub-id pub-id-type="pmid">16945870</pub-id></element-citation></ref><ref id="CR99"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shao</surname><given-names>X</given-names></name><name><surname>Guo</surname><given-names>X</given-names></name><name><surname>Esper</surname><given-names>F</given-names></name><name><surname>Weibel</surname><given-names>C</given-names></name><name><surname>Kahn</surname><given-names>JS</given-names></name></person-group><article-title>Seroepidemiology of group I human coronaviruses in children</article-title><source>J Clin Virol</source><year>2007</year><volume>40</volume><issue>3</issue><fpage>207</fpage><lpage>213</lpage><pub-id pub-id-type="doi">10.1016/j.jcv.2007.08.007</pub-id><?supplied-pmid 17889596?><pub-id pub-id-type="pmid">17889596</pub-id></element-citation></ref><ref id="CR100"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shay</surname><given-names>D</given-names></name><name><surname>Holman</surname><given-names>RC</given-names></name><name><surname>Roosevelt</surname><given-names>GE</given-names></name><name><surname>Clarke</surname><given-names>MJ</given-names></name><name><surname>Anderson</surname><given-names>LJ</given-names></name></person-group><article-title>Bronchiolitis-associated mortality and estimates of respiratory syncytial virus -associated deaths among US children, 1979&#x02013;1997</article-title><source>J Infect Dis</source><year>2001</year><volume>183</volume><fpage>16</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1086/317655</pub-id><?supplied-pmid 11076709?><pub-id pub-id-type="pmid">11076709</pub-id></element-citation></ref><ref id="CR101"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shadman</surname><given-names>KA</given-names></name><name><surname>Wald</surname><given-names>ER</given-names></name></person-group><article-title>A review of palivizumab and emerging therapies for respiratory syncytial virus</article-title><source>Expert Opin Biol Ther</source><year>2011</year><volume>11</volume><fpage>1455</fpage><lpage>1467</lpage><pub-id pub-id-type="doi">10.1517/14712598.2011.608062</pub-id><?supplied-pmid 21831008?><pub-id pub-id-type="pmid">21831008</pub-id></element-citation></ref><ref id="CR102"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shobugawa</surname><given-names>Y</given-names></name><name><surname>Saito</surname><given-names>R</given-names></name><name><surname>Sano</surname><given-names>Y</given-names></name><name><surname>Zaraket</surname><given-names>H</given-names></name><name><surname>Suzuki</surname><given-names>Y</given-names></name><name><surname>Kumaki</surname><given-names>A</given-names></name><name><surname>Dapat</surname><given-names>I</given-names></name><name><surname>Oguma</surname><given-names>T</given-names></name><name><surname>Yamaguchi</surname><given-names>M</given-names></name><name><surname>Suzuki</surname><given-names>H</given-names></name></person-group><article-title>Emerging genotypes of human respiratory syncytial virus subgroup A among patients in Japan</article-title><source>J Clin Microbiol</source><year>2009</year><volume>47</volume><issue>8</issue><fpage>2475</fpage><lpage>2482</lpage><pub-id pub-id-type="doi">10.1128/JCM.00115-09</pub-id><?supplied-pmid 19553576?><pub-id pub-id-type="pmid">19553576</pub-id></element-citation></ref><ref id="CR103"><label>103.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Spencer</surname><given-names>MJ</given-names></name><name><surname>Cherry</surname><given-names>JD</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Feigin</surname><given-names>RD</given-names></name><name><surname>Cherry</surname><given-names>JD</given-names></name></person-group><article-title>Adenoviral infections</article-title><source>Textbook of pediatric infectious diseases</source><year>1987</year><edition>2</edition><publisher-loc>Philadelphia</publisher-loc><publisher-name>Elsevier</publisher-name><fpage>1688</fpage><lpage>1708</lpage></element-citation></ref><ref id="CR104"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Straliotto</surname><given-names>SM</given-names></name><name><surname>Nestor</surname><given-names>SM</given-names></name><name><surname>Siqueira</surname><given-names>MM</given-names></name></person-group><article-title>Respiratory syncytial virus groups A and B in Porto Alegre, Brazil, from 1990 to 1995 and 1998</article-title><source>Mem Inst Oswaldo Cruz</source><year>2001</year><volume>96</volume><issue>2</issue><fpage>155</fpage><lpage>158</lpage><pub-id pub-id-type="doi">10.1590/S0074-02762001000200003</pub-id><?supplied-pmid 11285489?><pub-id pub-id-type="pmid">11285489</pub-id></element-citation></ref><ref id="CR105"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomazelli</surname><given-names>LM</given-names></name><name><surname>Vieira</surname><given-names>SE</given-names></name><name><surname>Leal</surname><given-names>AL</given-names></name><name><surname>Silva</surname><given-names>TS</given-names></name><name><surname>Oliveira</surname><given-names>DB</given-names></name><name><surname>Golono</surname><given-names>MA</given-names></name><name><surname>Gillio</surname><given-names>AE</given-names></name><name><surname>Stewien</surname><given-names>KE</given-names></name><name><surname>Erdman</surname><given-names>DD</given-names></name><name><surname>Durigon</surname><given-names>EL</given-names></name></person-group><article-title>Surveillance of eight respiratory v&#x000ed;ruses in clinical samples of pediatric patients in southeast Brazil</article-title><source>J Pediatr</source><year>2007</year><volume>83</volume><issue>5</issue><fpage>422</fpage><lpage>428</lpage><pub-id pub-id-type="doi">10.1590/S0021-75572007000600005</pub-id></element-citation></ref><ref id="CR106"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tregoning</surname><given-names>JS</given-names></name><name><surname>Schwarze</surname><given-names>J</given-names></name></person-group><article-title>Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology</article-title><source>Clin Microbiol Rev</source><year>2010</year><volume>23</volume><issue>1</issue><fpage>74</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1128/CMR.00032-09</pub-id><?supplied-pmid 20065326?><pub-id pub-id-type="pmid">20065326</pub-id></element-citation></ref><ref id="CR107"><label>107.</label><mixed-citation publication-type="other">Trento A, Abrego L, Rodriguez-Fernandes R, Gonzales-Sanches MI, Gonzales-Martines F, Delfraro A, Pascale JM, Arbiza J, Melero JA (2015) Conservation of G protein epitopes in respiratory syncytial virus (group a) despite broad genetic diversity: is antibody selection involved in virus evolution?. J Virol. piiJVI.00467&#x02013;15</mixed-citation></ref><ref id="CR108"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trento</surname><given-names>A</given-names></name><name><surname>Galiano</surname><given-names>M</given-names></name><name><surname>Videla</surname><given-names>C</given-names></name><name><surname>Carballal</surname><given-names>G</given-names></name><name><surname>Garc&#x000ed;a-Barreno</surname><given-names>B</given-names></name><name><surname>Melero</surname><given-names>JA</given-names></name><name><surname>Palomo</surname><given-names>C</given-names></name></person-group><article-title>Major changes in the G protein of human respiratory syncytial virus isolates introduced by a duplication of 60 nucleotides</article-title><source>J Gen Virol</source><year>2003</year><volume>84</volume><issue>pt 11</issue><fpage>3115</fpage><lpage>3120</lpage><pub-id pub-id-type="doi">10.1099/vir.0.19357-0</pub-id><?supplied-pmid 14573817?><pub-id pub-id-type="pmid">14573817</pub-id></element-citation></ref><ref id="CR109"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trento</surname><given-names>A</given-names></name><name><surname>Viegas</surname><given-names>M</given-names></name><name><surname>Galiano</surname><given-names>M</given-names></name><name><surname>Videla</surname><given-names>C</given-names></name><name><surname>Carballal</surname><given-names>G</given-names></name><name><surname>Mistchenko</surname><given-names>AS</given-names></name><name><surname>Melero</surname><given-names>JA</given-names></name></person-group><article-title>Natural history of human respiratory syncytial virus inferred from phylogenetic analysis of the attachment (G) glycoprotein with a 60-nucleotide duplication</article-title><source>J Virol</source><year>2006</year><volume>80</volume><issue>2</issue><fpage>975</fpage><lpage>984</lpage><pub-id pub-id-type="doi">10.1128/JVI.80.2.975-984.2006</pub-id><?supplied-pmid 16378999?><pub-id pub-id-type="pmid">16378999</pub-id></element-citation></ref><ref id="CR110"><label>110.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Tristram</surname><given-names>DA</given-names></name><name><surname>Welliver</surname><given-names>RC</given-names></name></person-group><article-title>Respiratory syncytial virus</article-title><source>Diagnostic procedure for viral, rickettsial and chlamydial infections</source><year>1996</year><edition>7</edition><publisher-loc>Washington, DC</publisher-loc><publisher-name>American Public Health Association</publisher-name></element-citation></ref><ref id="CR111"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsuchiya</surname><given-names>LRRV</given-names></name><name><surname>Costa</surname><given-names>LMD</given-names></name><name><surname>Raboni</surname><given-names>SM</given-names></name><name><surname>Nogueira</surname><given-names>MB</given-names></name><name><surname>Pereira</surname><given-names>LA</given-names></name><name><surname>Rotta</surname><given-names>I</given-names></name><name><surname>Takahashi</surname><given-names>GRA</given-names></name><name><surname>Coelho</surname><given-names>M</given-names></name><name><surname>Siqueira</surname><given-names>MM</given-names></name></person-group><article-title>Viral respiratory infection in Curitiba, Southern Brazil</article-title><source>J Infect</source><year>2005</year><volume>51</volume><fpage>401</fpage><lpage>407</lpage><pub-id pub-id-type="doi">10.1016/j.jinf.2004.12.002</pub-id><?supplied-pmid 16321652?><pub-id pub-id-type="pmid">16321652</pub-id></element-citation></ref><ref id="CR112"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsutsumi</surname><given-names>H</given-names></name><name><surname>Onuma</surname><given-names>M</given-names></name><name><surname>Suga</surname><given-names>K</given-names></name><name><surname>Honjo</surname><given-names>T</given-names></name><name><surname>Chiba</surname><given-names>Y</given-names></name><name><surname>Chiba</surname><given-names>S</given-names></name><name><surname>Ogra</surname><given-names>PL</given-names></name></person-group><article-title>Occurrence of respiratory syncytial virus subgroup A and B strains in Japan, 1980 to 1987</article-title><source>J Clin Microbiol</source><year>1988</year><volume>26</volume><fpage>1171</fpage><lpage>1174</lpage><?supplied-pmid 3290246?><pub-id pub-id-type="pmid">3290246</pub-id></element-citation></ref><ref id="CR113"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valdez</surname><given-names>O</given-names></name><name><surname>Martinez</surname><given-names>I</given-names></name><name><surname>Valdivia</surname><given-names>A</given-names></name><name><surname>Cancio</surname><given-names>R</given-names></name><name><surname>Sav&#x000f3;n</surname><given-names>C</given-names></name><name><surname>Goyenechea</surname><given-names>A</given-names></name><name><surname>Melero</surname><given-names>J</given-names></name></person-group><article-title>Unusual antigenic and genetic characteristics of human respiratory syncytial virus isolated in Cuba</article-title><source>J Virol</source><year>1998</year><volume>72</volume><fpage>7589</fpage><lpage>7592</lpage><pub-id pub-id-type="pmid">9696858</pub-id></element-citation></ref><ref id="CR114"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van den Hoogen</surname><given-names>BG</given-names></name><name><surname>van Doornum</surname><given-names>GJ</given-names></name><name><surname>Fockens</surname><given-names>JC</given-names></name><name><surname>Cornelissen</surname><given-names>JJ</given-names></name><name><surname>Beyer</surname><given-names>WE</given-names></name><name><surname>de Groot</surname><given-names>R</given-names></name><name><surname>Osterhaus</surname><given-names>AD</given-names></name><name><surname>Fouchier</surname><given-names>RA</given-names></name></person-group><article-title>Prevalence e clinical symptoms of human metapneumov&#x000ed;rus infection in hospitalized patients</article-title><source>J Infect Dis</source><year>2003</year><volume>188</volume><fpage>1571</fpage><lpage>1577</lpage><pub-id pub-id-type="doi">10.1086/379200</pub-id><?supplied-pmid 14624384?><pub-id pub-id-type="pmid">14624384</pub-id></element-citation></ref><ref id="CR115"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Venter</surname><given-names>M</given-names></name><name><surname>Madhi</surname><given-names>SA</given-names></name><name><surname>Tiemessen</surname><given-names>CT</given-names></name><name><surname>Schoub</surname><given-names>BD</given-names></name></person-group><article-title>Genetic diversity and molecular epidemiology of respiratory syncytial virus over four consecutive seasons in South Africa: identification of new subgroup A and B genotypes</article-title><source>J Gen Virol.</source><year>2001</year><volume>82</volume><issue>pt 9</issue><fpage>2117</fpage><lpage>2124</lpage><pub-id pub-id-type="doi">10.1099/0022-1317-82-9-2117</pub-id><?supplied-pmid 11514720?><pub-id pub-id-type="pmid">11514720</pub-id></element-citation></ref><ref id="CR116"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Se</surname><given-names>V</given-names></name><name><surname>Stewien</surname><given-names>KE</given-names></name><name><surname>Queir&#x000f3;z</surname><given-names>DAO</given-names></name><name><surname>Durigon</surname><given-names>EL</given-names></name><name><surname>Torok</surname><given-names>TJ</given-names></name><name><surname>Anderson</surname><given-names>LJ</given-names></name><name><surname>Miyao</surname><given-names>CR</given-names></name><name><surname>Hein</surname><given-names>N</given-names></name><name><surname>Botosso</surname><given-names>VF</given-names></name><name><surname>Pahl</surname><given-names>MM</given-names></name><name><surname>Gilio</surname><given-names>AE</given-names></name><name><surname>Ejzenberg</surname><given-names>B</given-names></name><name><surname>Okay</surname><given-names>Y</given-names></name></person-group><article-title>Clinical patterns and seasonal trends in respiratory syncytial v&#x000ed;rus hospitalizations in S&#x000e3;o Paulo, Brazil</article-title><source>Rev Inst Med Trop S&#x000e3;o Paulo</source><year>2001</year><volume>43</volume><fpage>125</fpage><lpage>131</lpage><pub-id pub-id-type="doi">10.1590/S0036-46652001000300002</pub-id><pub-id pub-id-type="pmid">11452319</pub-id></element-citation></ref><ref id="CR117"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walsh</surname><given-names>EE</given-names></name><name><surname>Falsey</surname><given-names>AR</given-names></name><name><surname>Swinburne</surname><given-names>IA</given-names></name><name><surname>Formica</surname><given-names>MA</given-names></name></person-group><article-title>Reverse transcription polymerase chain reaction (RT&#x02013;PCR) for diagnosis of respiratory infection in adults: use of single-tube &#x0201c;hanging droplet&#x0201d; nested PCR</article-title><source>J Med Virol</source><year>2001</year><volume>63</volume><fpage>259</fpage><lpage>263</lpage><pub-id pub-id-type="doi">10.1002/1096-9071(200103)63:3&#x0003c;259::AID-JMV1010&#x0003e;3.0.CO;2-X</pub-id><?supplied-pmid 11170067?><pub-id pub-id-type="pmid">11170067</pub-id></element-citation></ref><ref id="CR118"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wertz</surname><given-names>GW</given-names></name><name><surname>Collins</surname><given-names>PL</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Gruber</surname><given-names>C</given-names></name><name><surname>Levine</surname><given-names>S</given-names></name><name><surname>Ball</surname><given-names>LA</given-names></name></person-group><article-title>Nucleotide sequence of the G protein gene of human respiratory syncytial virus reveals an unusual type of viral membrane protein</article-title><source>Proc Natl Acad Sci U S A</source><year>1985</year><volume>82</volume><issue>12</issue><fpage>4075</fpage><lpage>4079</lpage><pub-id pub-id-type="doi">10.1073/pnas.82.12.4075</pub-id><?supplied-pmid 3858865?><pub-id pub-id-type="pmid">3858865</pub-id></element-citation></ref><ref id="CR119"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>BG</given-names></name><name><surname>Gouws</surname><given-names>E</given-names></name><name><surname>Boschi-Pinto</surname><given-names>C</given-names></name><name><surname>Bryce</surname><given-names>J</given-names></name><name><surname>Dye</surname><given-names>C</given-names></name></person-group><article-title>Estimates of world-wide distribution of child deaths from acute respiratory infections</article-title><source>Lancet Infect Dis</source><year>2002</year><volume>2</volume><fpage>25</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(01)00170-0</pub-id><?supplied-pmid 11892493?><pub-id pub-id-type="pmid">11892493</pub-id></element-citation></ref><ref id="CR120"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>SD</given-names></name><name><surname>Roberts</surname><given-names>K</given-names></name><name><surname>Hammond</surname><given-names>K</given-names></name><name><surname>Ayres</surname><given-names>JG</given-names></name><name><surname>Cane</surname><given-names>PC</given-names></name></person-group><article-title>Estimation of incidence of respiratory syncytial virus infection in schoolchildren using salivary antibodies</article-title><source>J Med Virol</source><year>2000</year><volume>61</volume><fpage>81</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1096-9071(200005)61:1&#x0003c;81::AID-JMV13&#x0003e;3.0.CO;2-O</pub-id><?supplied-pmid 10745237?><pub-id pub-id-type="pmid">10745237</pub-id></element-citation></ref><ref id="CR121"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zelaya</surname><given-names>EAC</given-names></name><name><surname>Petterson</surname><given-names>CA</given-names></name><name><surname>Forsgren</surname><given-names>M</given-names></name><name><surname>Orvell</surname><given-names>C</given-names></name><name><surname>Strannegard</surname><given-names>O</given-names></name></person-group><article-title>Respiratory syncytial virus infection in hospitalized patients and healthy children in El Salvador</article-title><source>Am J Trop Med Hyg</source><year>1994</year><volume>51</volume><fpage>577</fpage><lpage>584</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.1994.51.577</pub-id><pub-id pub-id-type="pmid">7985749</pub-id></element-citation></ref><ref id="CR122"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>H</given-names></name><name><surname>Peret</surname><given-names>TC</given-names></name><name><surname>Randoph</surname><given-names>VB</given-names></name><name><surname>Crowley</surname><given-names>JC</given-names></name><name><surname>Anderson</surname><given-names>LJ</given-names></name></person-group><article-title>Strain-specific reverse transcriptase PCR assay: means to distinguish candidate vaccine from wilde-type strains of respiratory syncytial virus</article-title><source>J Clin Microbiol</source><year>1996</year><volume>34</volume><fpage>334</fpage><lpage>337</lpage><?supplied-pmid 8789010?><pub-id pub-id-type="pmid">8789010</pub-id></element-citation></ref><ref id="CR123"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>Q</given-names></name><name><surname>McAuliffe</surname><given-names>JM</given-names></name><name><surname>Patel</surname><given-names>NK</given-names></name><name><surname>Palmer-Hill</surname><given-names>FJ</given-names></name><name><surname>Yang</surname><given-names>CF</given-names></name><name><surname>Liang</surname><given-names>B</given-names></name><etal/></person-group><article-title>Analysis of respiratory syncytial virus preclinical and clinical variants resistant to neutralization by monoclonal antibodies palivizumab and/or motavizumab</article-title><source>J Infect Dis</source><year>2011</year><volume>203</volume><fpage>674</fpage><lpage>682</lpage><pub-id pub-id-type="doi">10.1093/infdis/jiq100</pub-id><?supplied-pmid 21208913?><pub-id pub-id-type="pmid">21208913</pub-id></element-citation></ref><ref-list id="BSec1"><title>Web Sites</title><ref id="CR124"><label>124.</label><mixed-citation publication-type="other">CDC- Center for Disease Control and Prevention (2014) Respiratory syncytial virus circulation in the United States, July 2012-Jun 2014. MMWR 62:141&#x02013;144. Accessed [Feb 2016]</mixed-citation></ref><ref id="CR125"><label>125.</label><mixed-citation publication-type="other">ICTV. International Committee on Taxonomy of Viruses. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.ictvonline.org/virusTaxonomy.asp">http://www.ictvonline.org/virusTaxonomy.asp</ext-link>. [Mar 2015]. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.ictvonline.org/virusTaxonomy.asp">http://www.ictvonline.org/virusTaxonomy.asp</ext-link>. [3 Mar 2016]</mixed-citation></ref></ref-list></ref-list></back></article>